<!DOCTYPE html>

<html lang="en">
<!--[326055|cc|]--><head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>Afinitor: Side effects, cost, uses, and more (everolimus)</title>
<meta property='og:url' content='https://www.medicalnewstoday.com/articles/326055.php'/>		<meta property="og:type" content="article"/>
		<meta property="og:site_name" content="Medical News Today"/>
		<meta property="og:title" content="Afinitor: Side effects, cost, uses, and more (everolimus)"/>
					<meta property="og:description" content="Afinitor (everolimus) is a brand-name prescription medication. It’s used to treat certain types of cancers, tumors, and seizures. It comes as an oral tablet (Afinitor) and as a tablet for oral suspension (Afinitor Disperz). Learn about side effects, cost, uses and more."/>
			<meta name="description" content="Afinitor (everolimus) is a brand-name prescription medication. It’s used to treat certain types of cancers, tumors, and seizures. It comes as an oral tablet (Afinitor) and as a tablet for oral suspension (Afinitor Disperz). Learn about side effects, cost, uses and more."/>
						<meta property="og:image" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
					<meta property="fb:admins" content="1658973110"/>
		<meta property="fb:app_id" content="147184211975697"/>
					<meta itemprop="description" content="Afinitor (everolimus) is a brand-name prescription medication. It’s used to treat certain types of cancers, tumors, and seizures. It comes as an oral tablet (Afinitor) and as a tablet for oral suspension (Afinitor Disperz). Learn about side effects, cost, uses and more."/>
						<meta itemprop="image" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
					<meta name="twitter:domain" content="medicalnewstoday.com"/>
		<meta name="twitter:card" content="summary_large_image"/>
		<meta name="twitter:site" content="@mnt"/>
		<meta name="twitter:title" content="Afinitor: Side effects, cost, uses, and more (everolimus)"/>
					<meta name="twitter:description" content="Afinitor (everolimus) is a brand-name prescription medication. It’s used to treat certain types of cancers, tumors, and seizures. It comes as an oral tablet (Afinitor) and as a tablet for oral suspension (Afinitor Disperz). Learn about side effects, cost, uses and more."/>
					<meta name="twitter:creator" content="@mnt"/>
					<meta name="twitter:image:src" content="https://cdn-prod.medicalnewstoday.com/structure/images/social/mnt_sharing.png"/>
			<META name="rating" content="general">
<META http-equiv="Cache-Control" content="no-cache">
<meta name="p:domain_verify" content="ca332f19ebf583ba72eff99cc210a982"/>
<meta name="msvalidate.01" content="65DAC77377665AE872AC660E37807BC6" />
<META http-equiv="bulletin-text" content="Copyright">

			<link rel="canonical" href="https://www.medicalnewstoday.com/articles/326055.php">
			
<link rel="shortcut icon" type="image/png" href="https://cdn-prod.medicalnewstoday.com/favicon.png">
<link rel="icon" sizes="32x32" href="https://cdn-prod.medicalnewstoday.com/favicon.ico">
<link rel="apple-touch-icon" type="image/png" href="https://cdn-prod.medicalnewstoday.com/apple-touch-icon.png">

	<link rel="alternate" type="application/rss+xml" title="Medical News Today - Health News Headlines RSS Feed" href="https://rss.medicalnewstoday.com/featurednews.xml">
	<link rel="alternate" type="application/json" title="Medical News Today - Health News Headlines JSON Feed" href="https://rss.medicalnewstoday.com/json/featurednews.json">
	
<meta http-equiv="x-dns-prefetch-control" content="on">
<link rel="preconnect dns-prefetch" href="//cdn-prod.medicalnewstoday.com" crossorigin>
<link rel="preconnect dns-prefetch" href="//cdn2.medicalnewstoday.com" crossorigin>


	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff2">
	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-Light.woff2">
	<link rel="preload" as="font" crossorigin="crossorigin" href="/structure/fonts/ProximaNova/ProximaNova-Regular.woff2">


	<style>
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-ExtraBold.woff') format('woff');
			font-weight:900;
			font-display: swap;}
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-Light.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-Light.woff') format('woff');
			font-weight:200;
			font-style:lighter;
			font-display: swap;}
		@font-face {
			font-family: 'ProximaNova';
			src: url('/structure/fonts/ProximaNova/ProximaNova-Regular.woff2') format('woff2'),
			url('/structure/fonts/ProximaNova/ProximaNova-Regular.woff') format('woff');
			font-weight:400;
			font-weight:normal;
			font-style:normal;
			font-display: swap;}

		@font-face {
			font-family: 'ProximaNova';
			src: url('https://cdn-prod.medicalnewstoday.com/structure/fonts/ProximaNova/ProximaNova-Bold.woff2') format('woff2'),
			url('https://cdn-prod.medicalnewstoday.com/structure/fonts/ProximaNova/ProximaNova-Bold.woff') format('woff');
			font-weight:600;
			font-weight:bold;
			font-style:bold;
			font-display: swap;}

		@font-face {
			font-family: 'Arnhem';
			src: url('https://cdn-prod.medicalnewstoday.com/structure/fonts/Arnhem/ArnhemPro-Bold.woff') format('woff');
			font-weight:600;
			font-weight:bold;
			font-style:bold;
			font-display: swap;}
	</style>





	
<link href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css" rel="stylesheet" integrity="sha384-wvfXpqpZZVQGK6TAh5PVlGOfQNHSoD2xbE+QkPxCAFlNEevoEH3Sl0sibVcOQVnN" crossorigin="anonymous">

					<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_default_redesign_7721.css?v=190904" type="text/css" media="all" />
		

		



					<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_print_redesign_7721.css?v=20181203" type="text/css" media="print">
				
		


<!--[if lt IE 9]>
<script src="//html5shim.googlecode.com/svn/trunk/html5.js"></script>

			<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/out/mnt_ie.css" type="text/css" media="all" />
	


	<![endif]-->
<!--[if IE 7]>

<script src="//ie7-js.googlecode.com/svn/version/2.1(beta4)/IE7.js"></script>
<![endif]-->	
<!--[if IE 9]>
<script src="//ie7-js.googlecode.com/svn/version/2.1(beta4)/IE9.js"></script>
<![endif]-->


<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.2, maximum-scale=2.0, user-scalable=1"><!--desktop-->


<noscript>
<link rel="stylesheet" href="https://cdn-prod.medicalnewstoday.com/structure/styles/styles_noscript.css" type="text/css" media="all" />	
</noscript>
<script type="text/javascript" >
			var glob_mntcookie = 1;
	  </script>
<script>

glob_JS=(typeof glob_JS === 'undefined')?{'GAInit':[],'GA':[],"ExternalJS":[],"AD":[]}:glob_JS;

glob_TrueOnGDPR=(glob_mntcookie!=1);

//if use GDPR is true, we need this flag to make sure ga queue can ber execute after ga is ready
glob_isGaReady=!glob_TrueOnGDPR;



if(typeof fireOrSaveGoogleAdFunctions === 'undefined'){



    function fireOrSaveGoogleAdFunctions(adFunction){

        if(!glob_TrueOnGDPR){

            adFunction();

        }else{

            if(typeof fireOrSaveGoogleADs === 'undefined'){
                //save ad event in queue
                glob_JS.AD.push(adFunction);
            }else{
                //let next function to determine save or fire ad function
                fireOrSaveGoogleADs(adFunction);

            }
        }

    }

    function fireOrSaveJsFunctions(jsType,jsFunction){

        if(!glob_TrueOnGDPR && jsType!=0){
            //if GDPR already accept, and func type is not ga event, just exec

            jsFunction()

        }else if(!glob_TrueOnGDPR && jsType===0) {
            //for ga event only

            if(glob_isGaReady) {
                //if ga ready, call the function
                jsFunction();
            }else{
                //if user accept GDPR, but ga not ready, still push new command into queue
                glob_JS.GA.push(jsFunction);

            }

        }else{

                if(jsType<0){
                    jsType='GAInit'
                }else if(jsType==0){
                    jsType='GA';
                }else{
                    jsType='ExternalJS';
                }

                if(typeof fireJS === 'undefined'){
                    //save ad event in queue


                    if(jsType=='GAInit'){

                        glob_JS.GAInit.push(jsFunction);

                    }else if(jsType=='GA') {

                        glob_JS.GA.push(jsFunction);
                    }else
                    {
                        //default is other js
                        glob_JS.ExternalJS.push(jsFunction);
                    }


                }else{
                    //let next function to determine save or fire ad function
                    fireJS(jsType,jsFunction);

                }
            }
    }



    function loadScript(url, parameters,callback){



        var script = document.createElement("script");
        script.type = "text/javascript";


        //add custom attribute
        for (var key in parameters) {
            if (parameters.hasOwnProperty(key)) {
                script.setAttribute(key,parameters[key]);
            }
        }


        if (script.readyState){  //IE
            script.onreadystatechange = function(){
                if (script.readyState == "loaded" ||
                    script.readyState == "complete"){
                    script.onreadystatechange = null;
                    callback();
                }
            };
        } else {  //Others
            script.onload = function(){

                if(typeof callback === 'function'){
                    callback();
                }

            };
        }

        script.src = url;
        document.getElementsByTagName("head")[0].appendChild(script);
    }



}

</script>




<!--<script type='text/javascript'>
(function() {
var useSSL = 'https:' == document.location.protocol;
var src = (useSSL ? 'https:' : 'http:') +
'//www.googletagservices.com/tag/js/gpt.js';
document.write('<scr' + 'ipt src="' + src + '"></scr' + 'ipt>');
})();
</script>-->


<script type="text/javascript">
	//CMP	
 	var isEEA = false;
 	var passEEACheck = false;

	var metadata = 'BOSk20WOSk20WABABBENBR-AAAAeCAFAAUABwAEAANABCA';
	var purposeConsents = { 1: true, 2: true, 3: true, 4: true, 5: true };
	var vendorConsents = { 10:true, 28: true, 32: true, 52: true, 132: true };

		function __cmp(cmd, p, cb) {
			if (cmd === 'getVendorConsents' || cmd === 'getConsentData') {
				cb({
					hasGlobalScope: true,
					gdprApplies: isEEA,
					metadata: metadata,
					consentData: metadata,
					purposeConsents: purposeConsents,
					vendorConsents: vendorConsents
				}, true);
			} else if (cmd === 'ping') {
				cb({gdprAppliesGlobally: false, cmpLoaded: isEEA});
			} else {
				throw new Error('Invalid CMP command '+ cmd);
			}
		}
</script>
<!-- <script async src="//js-sec.indexww.com/ht/p/184901-208206248649346.js"></script> -->
<!-- <script async src="//js-sec.indexww.com/ht/p/180447-192872210293780.js"></script> -->
<script type="text/javascript">
	fireOrSaveJsFunctions(1,function(){
		(function() {
			var indexWrapper = document.createElement("script");
			indexWrapper.async = true;
			indexWrapper.type = "text/javascript";
			var useSSL = "https:" == document.location.protocol;
			indexWrapper.src = (useSSL ? "https:" : "http:") + "//js-sec.indexww.com/ht/p/180447-192872210293780.js";
			var node =document.getElementsByTagName("script")[0];
			node.parentNode.insertBefore(indexWrapper, node);
		})();
	});
</script>
<script type="text/javascript">
fireOrSaveJsFunctions(1,function(){
	window.headertag = window.headertag || {};
	window.headertag.pagetype='drugs';
});
</script>

<script type="text/javascript">
	//ADBRIDG MIGRATION: Load the Adbridg library directly after the GPT library. 
  var AdBridg = AdBridg || {};
  AdBridg.cmd = AdBridg.cmd || [];
  window.adbridgFallback = function() {
		console.log('ADBRIDG MIGRATION: library failed to load; falling back to GPT');
    var dq = [], l = [], ls = {}, lf = [], es;
    var rl = function(f) {return function(){var a=arguments, x=function(){f.apply(null,a)};lf.push(x);pl()}}
    var pl = function() {if(!l.length){while(lf.length){(lf.shift())()}}}
    dq.process = function() { while(dq.length) { googletag.display(dq.shift()); }}
    AdBridg.defineSlot = function(p, s, d) { return googletag.defineSlot(p, s, d).addService(googletag.pubads()); }
    AdBridg.defineOutOfPageSlot = function(p, d) { return googletag.defineOutOfPageSlot(p, d).addService(googletag.pubads()); }
    AdBridg.destroySlots = function(s) { return googletag.destroySlots(s); }
    AdBridg.display = function(d) { dq.push(d); if (es) { dq.process(); }}
    AdBridg.refresh = function(s, o) { googletag.pubads().refresh(s, o); }
    AdBridg.render = function() { }
    AdBridg.serve = function() { googletag.enableServices(); es=1; dq.process(); }
    AdBridg.sizeMapping = function() { return googletag.sizeMapping(); }
    AdBridg.useSizeMapping = function() { }
    AdBridg.lock = function(s) {if(ls[s]){ls[s]=null;return;}l.push(s);pl()}
    AdBridg.unlock = function(s) {var f=0; for(var i=0;i<l.length;++i){if(l[i]==s){l.splice(i,1);f=1}}; if(!f){ls[s]=1} pl()}
		AdBridg.cmd.push = function(f) {
			if (typeof(f)=='object') {
				var api_fallback = function(o) {
					googletag.cmd.push(function() {
						var fl;
						if (o.gpt_path) {
							var u=AdBridg.defineSlot(o.gpt_path,o.size||[],o.dom_id);
							if(o.size_map) {
								var m = googletag.sizeMapping();
								for(var oi=0;oi<o.size_map.length;oi++){m=m.addSize(o.size_map[oi].viewport, o.size_map[oi].sizes);}
								u.defineSizeMapping(m.build());
							}
							if(o.events) {
								if(o.events["gpt.defined"]){o.events["gpt.defined"](u);}
								fl = function(a,b){if(o.events[a]){googletag.pubads().addEventListener(b,function(e){if(e.slot===u){o.events[a](u,e)}})}}
								fl("gpt.rendered",'slotRenderEnded');
								fl("gpt.viewed",'impressionViewable');
								fl("gpt.visibilityChanged",'slotVisibilityChanged');
							}
						} else if (o.events) {
							fl = function(a,b){if(o.events[a]){googletag.pubads().addEventListener(b,function(e){o.events[a](a,e)})}}
							fl("gpt.render_raw",'slotRenderEnded');
							fl("gpt.viewed_raw",'impressionViewable');
						}
					});
				}
				if(f.length){for(var i=0;i<f.length;++i){api_fallback(f[i]);}}else{api_fallback(f);}
				f=function(){AdBridg.serve()}
			}
			return googletag.cmd.push(f);
		}
		while (AdBridg.cmd.length) { AdBridg.cmd.push(AdBridg.cmd.shift()); }
  };
	fireOrSaveJsFunctions(1, function() {
		(function() {
	      var adb = document.createElement("script");
	      adb.async = true;
	      adb.type = "text/javascript";
	      adb.src = '//prod.adspsp.com/adb.2418030m.min.js';
	      var node = document.getElementsByTagName('script')[0];
	      node.parentNode.insertBefore(adb, node);

	      // Return control to GPT if the AdBridg library fails to load.
	      adb.onerror = function() {
	        if (AdBridg.exists) { return; }
	        document.createElement('IMG').src = '//adspsp.com/pt/2418030/3/1/?e=0';
	        window.adbridgFallback();
	      }
	  })();
	});
</script>

<!-- Load DFP -->
<script type="text/javascript">
	var googletag = googletag || { };
	googletag.cmd = googletag.cmd || [ ];
	fireOrSaveJsFunctions(1,function(){
		(function() {
			var gads = document.createElement("script");
			gads.async = true;
			gads.type = "text/javascript";
			var useSSL = "https:" == document.location.protocol;
			gads.src = (useSSL ? "https:" : "http:") + "//www.googletagservices.com/tag/js/gpt.js";
			var node =document.getElementsByTagName("script")[0];
			node.parentNode.insertBefore(gads, node);
		})();
	});
</script>

<!--New header bidding-->
<script>
var amzn_win=window,amzn_c=5,amzn_x=0;while(amzn_x<amzn_c){amzn_win=amzn_win.parent;if(amzn_win.apstag)try{amzn_win.apstag.renderImp(document,"%%PATTERN:amzniid%%");amzn_x=amzn_c}catch(e){}amzn_x++};
</script> 

<script type="text/javascript">
	fireOrSaveGoogleAdFunctions(function() {
		AdBridg.cmd.push(function () {
			// ADBRIDG MIGRATION: this command to set AdSense is one of the few
			// GPT commands that should not be replaced with our library proxy.
			googletag.pubads().set("adsense_background_color", "FFFFFF");
		});
	});
</script>


<script type="text/javascript">
	var googleDegfaultAdVars = {"main":"'urology-nephrology'","k1":"'kidneycancer'","k2":"'cancer'","k3":"'health'","uniq":"'326055'","msiteID":"'afinitorcdi'","msiteactive":"'True'","sponsoredPageNid":"''"};
	var googleAdSlotInfo = [];
	
	fireOrSaveGoogleAdFunctions(function(){
		AdBridg.cmd.push({
		  config: {
		    k1: googleDegfaultAdVars.k1 || "",
		    k2: googleDegfaultAdVars.k2 || ""
		  }
		});	
	});
	
</script>

<!-- End of old ads area -->
<script type='text/javascript'>
//Page level targeting setup
var adRPV = Math.floor(Math.random()*100)+1;
adRPV = adRPV.toString();

fireOrSaveGoogleAdFunctions(function(){
// ADBRIDG MIGRATION: the `cmd` function needs to run through AdBridg, but the
// setTargeting methods should stay native to GPT.
AdBridg.cmd.push(function() {
	googletag.pubads().setTargeting('rpv', adRPV);
	//We need to add a new key for 'url'
    googletag.pubads().setTargeting('url', encodeURI(location.pathname));

    //Set default targeting first
            if (typeof googleDegfaultAdVars !== "undefined") {
            for (var k in googleDegfaultAdVars) {
                if (k == "sub" || googleDegfaultAdVars[k].toString().indexOf(",") > -1) {
                    var finalOutput = googleDegfaultAdVars[k].split(',');
                    //Remove the single qoute
                    for (var i in finalOutput) {
                        if (finalOutput[i].trim().toString().indexOf("'") == 0) {
                            finalOutput[i] = finalOutput[i].trim().slice(1, -1);
                        } else {
    						finalOutput[i] = finalOutput[i].trim();
                        }
                    }
                } else {
                    if (googleDegfaultAdVars[k].toString().indexOf("'") == 0) {
                        //if it got single qoute inside, we remove it
                        var finalOutput = googleDegfaultAdVars[k].slice(1, -1);
                    } else {
                        var finalOutput = googleDegfaultAdVars[k];
                    }
                }
                googletag.pubads().setTargeting(k, finalOutput);
            }
        }
    	//googletag.pubads().enableAsyncRendering(); // enable async loading
	// Disable initial load, we will use refresh() to fetch ads.
	// Calling this function means that display() calls just
	// register the slot as ready, but do not fetch ads for it.
	// googletag.pubads().disableInitialLoad();
 //  	googletag.pubads().enableSingleRequest();
    // googletag.pubads().enableLazyLoad({
    //     fetchMarginPercent: 50,  // Fetch slots within 5 viewports.
    //     renderMarginPercent: 30,  // Render slots within 2 viewports.
    //     mobileScaling: 2.0  // Double the above values on mobile.
    // });
	// googletag.enableServices();
    // ADBRIDG MIGRATION: by default, we enable single request, disable initial
    // load, and async rendering is enabled by default (GPT no longer supports
    // synchronous rendering as of 2019-01-21.)
    // All we need to do now is tell AdBridg to begin serving the ads.
    // AdBridg.serve();
    // console.log("serve happened in page level");

});
});
</script>
<script>
// check viewport for resize events and reload ads (1000ms delay)
var resizeTimer;
var width = window.innerWidth;

function resizer() {
	//Check to see if the width is changed 
	var newWidth = window.innerWidth;
	if (width != newWidth) {
		// check if we've crossed a break point (only need to refresh if crossing the 1000px break point)
		if (width >= 1000 && newWidth < 1000) {
			
							// DECREASE IN WIDTH
				fireOrSaveGoogleAdFunctions(function() {
					AdBridg.cmd.push(function () {
						if (typeof window.DLB1 !== "undefined") {
							AdBridg.refresh([window.DLB1]);
						}
					});
				});
			
			// send resize+refresh event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / Shrink / Ad refresh', eventLabel: 'Resize / Shrink / Ad refresh'});});
			
		} else if (width < 1000 && newWidth >= 1000) {
			
			// INCREASE IN WIDTH
			// 
							if(typeof window.DLB1 !== "undefined"){
					AdBridg.refresh([window.DLB1]);	
				}
						
			// send resize+refresh event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / Grow / Ad refresh', eventLabel: 'Resize / Grow / Ad refresh'});});
			
		} else {
			// send resize event
			fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'Browser Width', eventAction: 'Resize / No ad refresh', eventLabel: 'Resize / No ad refresh'});});
		}
	}

	width = newWidth;
}

window.addEventListener("resize", function(){ 
	clearTimeout(resizeTimer);
	resizeTimer = setTimeout(resizer, 1000);
});

</script>

<!--New header bidding-->
<script>
		!function(a9,a,p,s,t,A,g){if(a[a9])return;function q(c,r){a[a9]._Q.push([c,r])}a[a9]={init:function(){q("i",arguments)},fetchBids:function(){q("f",arguments)},setDisplayBids:function(){},_Q:[]};A=p.createElement(s);A.async=!0;A.src=t;g=p.getElementsByTagName(s)[0];g.parentNode.insertBefore(A,g)}("apstag",window,document,"script","//c.amazon-adsystem.com/aax2/apstag.js");


		var initParams = {
			pubID: '3083',
			adServer: 'googletag'
		};


		fireOrSaveJsFunctions(1,function(){

			if (passEEACheck||(isEEA&&glob_mntcookie)) {
				__cmp('getConsentData', null, function(vendorConsentData, success) {
					
					initParams.gdpr = { enabled: true, consent: vendorConsentData.metadata };
					apstag.init(initParams);
				});
			} else {
				apstag.init(initParams);
			}

	 })

</script>

	


	<script type="text/javascript">
	this.top.location!==this.location&&(this.top.location=this.location);
	</script>
	<style>.async-hide { opacity: 0 !important} </style>
<script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date;
h.end=i=function(){s.className=s.className.replace(RegExp(' ?'+y),'')};
(a[n]=a[n]||[]).hide=h;setTimeout(function(){i();h.end=null},c);h.timeout=c;
})(window,document.documentElement,'async-hide','dataLayer',4000,
{'GTM-W59HFNJ':true});</script>

	<script type="text/javascript">

			<!-- GA Universal Code 2014-08 (obfuscated) -->

			eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('5(-1,2(){(2(i,s,o,g,r,a,m){i[\'c\']=r;i[r]=i[r]||2(){(i[r].q=i[r].q||[]).e(d)},i[r].l=1*j h();a=s.b(o),m=s.6(o)[0];a.7=1;a.8=g;m.9.k(a,m)})(y,A,\'z\',\'//x.n-3.t/3.u\',\'4\')});5(-1,2(){4(\'v\',\'p-w-1\',\'f\')});',37,37,'||function|analytics|ga|fireOrSaveJsFunctions|getElementsByTagName|async|src|parentNode||createElement|GoogleAnalyticsObject|arguments|push|auto||Date||new|insertBefore|||google||UA||||com|js|create|849615|www|window|script|document'.split('|')))


	</script>
		<script type="text/javascript">
	/*
	CSS Browser Selector v0.4.0 (Nov 02, 2010)
	Rafael Lima (http://rafael.adm.br)
	http://rafael.adm.br/css_browser_selector
	License: http://creativecommons.org/licenses/by/2.5/
	Contributors: http://rafael.adm.br/css_browser_selector#contributors
	*/
	function css_browser_selector(u){var ua=u.toLowerCase(),is=function(t){return ua.indexOf(t)>-1},g='gecko',w='webkit',s='safari',o='opera',m='mobile',h=document.documentElement,b=[(!(/opera|webtv/i.test(ua))&&/msie\s(\d)/.test(ua))?('ie ie'+RegExp.$1):is('firefox/2')?g+' ff2':is('firefox/3.5')?g+' ff3 ff3_5':is('firefox/3.6')?g+' ff3 ff3_6':is('firefox/3')?g+' ff3':is('gecko/')?g:is('opera')?o+(/version\/(\d+)/.test(ua)?' '+o+RegExp.$1:(/opera(\s|\/)(\d+)/.test(ua)?' '+o+RegExp.$2:'')):is('konqueror')?'konqueror':is('blackberry')?m+' blackberry':is('android')?m+' android':is('chrome')?w+' chrome':is('iron')?w+' iron':is('applewebkit/')?w+' '+s+(/version\/(\d+)/.test(ua)?' '+s+RegExp.$1:''):is('mozilla/')?g:'',is('j2me')?m+' j2me':is('iphone')?m+' iphone':is('ipod')?m+' ipod':is('ipad')?m+' ipad':is('mac')?'mac':is('darwin')?'mac':is('webtv')?'webtv':is('win')?'win'+(is('windows nt 6.0')?' vista':''):is('freebsd')?'freebsd':(is('x11')||is('linux'))?'linux':'','js']; c = b.join(' '); h.className += ' '+c; return c;}; css_browser_selector(navigator.userAgent);
	</script>
	<script type="text/javascript">
var viewportWidth = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);
var viewportHeight = Math.max(document.documentElement.clientHeight, window.innerHeight || 0);

	switch (true) {
		case viewportWidth > 1360:
			var viewportBreakpoint = 'Desktop - XL';
			break;
		case viewportWidth > 1200:
			var viewportBreakpoint = 'Desktop - L';
			break;
		case viewportWidth > 1000:
			var viewportBreakpoint = 'Desktop - M';
			break;
		default:
			var viewportBreakpoint = 'Desktop - S';
	}
	
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension20', viewportBreakpoint);});

var existUserId=false;
var vanillaAjax=function(url,httpMethod,data,headerJsonString){

	var request = new XMLHttpRequest();


	request.open(httpMethod, url, true);


	//set header if exist
	try{
		var headerObj=JSON.parse(headerJsonString);

		for (var headerName in headerObj) {

			//optional check for properties from prototype chain
			if (headerObj.hasOwnProperty(headerName)) {
				//no a property from prototype chain

				var headerValue = headerObj[headerName];
				request.setRequestHeader(headerName,headerValue);

			}
		}

	}catch(e){
		console.log("Set datadog api header failed");
		//don't set header if something wrong;
	}




	request.onload = function() {

		if (request.status >= 200 && request.status < 400) {
			// Success!
			var resp = request.responseText;

		} else {
			// We reached our target server, but it returned an error

		}
	};

	request.onerror = function() {
		// There was a connection error of some sort
	};

	request.send(data);

};



function getUrlVars(targetField) {
	var vars = {};
	var parts = window.location.href.replace(/[?&]+([^=&]+)=([^&]*)/gi,
	function(m,key,value) {
		vars[key] = value;
	});

	if(typeof vars[targetField] !== "undefined"){

		return vars[targetField];

	}else{

		return "";
 	}

}


fireOrSaveJsFunctions(0,function() {ga('set', 'dimension35', getUrlVars("tc"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension36', getUrlVars("subid"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension37', getUrlVars("subid2"));});
fireOrSaveJsFunctions(0,function() {ga('set', 'dimension38', getUrlVars("apsid"));});


//set dimension34 value if exist

if(existUserId){

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension34', existUserId);});

}else if(getUrlVars("apid")){

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension34', getUrlVars("apid"));});

	vanillaAjax("/account/message-session-setter.php","POST","activation_platform_user_id="+getUrlVars("apid"),"{\"Content-type\":\"application/x-www-form-urlencoded\"}");

}

//will be called from newsletter register.
function setUserId(userId){

ga('set', 'dimension34', ""+userId);

}

fireOrSaveJsFunctions(0,function() {ga('set', 'dimension40', 'Catherine C. Peng, PharmD, BCPS');});
		

fireOrSaveJsFunctions(0,function() {ga('set', {
'dimension1': "no",
'dimension2': "drugs_tabbed",
'dimension3': "Urology / Nephrology",
'dimension5': "week",
'dimension6': "desktop",
'dimension12': "2019-08-31",
'dimension17': "7721",
'dimension21': "2",
'dimension23': "Victor Nguyen, PharmD, MS",
'dimension27': "1",
'dimension28': "kidneycancer",
'dimension29': "cancer"
});});

if (window.devicePixelRatio) {
	var pixelRatio = (window.devicePixelRatio >= 1.5) ? "HiDPI" : "1X";
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension7', pixelRatio);});
}

	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension10', viewportWidth);});
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension11', viewportHeight);});
	
	var MNT_ga_paramKey = (document.location.search.indexOf('?') > -1 ? '&' : '?');
	var MNT_ga_url_msId_fragment = MNT_ga_paramKey + 'gaPage=[afinitorcdi]';  
	var MNT_ga_url_msId = document.location.pathname + document.location.search + MNT_ga_url_msId_fragment;
	
		fireOrSaveJsFunctions(0,function() {ga('set', 'page', MNT_ga_url_msId);});
	fireOrSaveJsFunctions(0,function() {ga('set', 'dimension16', 'afinitorcdi');});fireOrSaveJsFunctions(0,function() {ga('require', 'GTM-W59HFNJ');});
fireOrSaveJsFunctions(0,function() {ga('send', 'pageview');});

setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 030','326055')});",30000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 050','326055')});",50000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 070','326055')});",70000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 090','326055')});",90000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 110','326055')});",110000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 130','326055')});",130000)
setTimeout("fireOrSaveJsFunctions(0,function() {ga('send','event','Engagement Time','Engagement 150','326055')});",150000)
</script>
<script>
	fireOrSaveJsFunctions(1,function() {

		var _qevents = _qevents || [];

		(function() {
			var elem = document.createElement('script');
			//elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js";
			elem.src = "https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/quant.js";
			elem.async = true;
			elem.type = "text/javascript";
			var scpt = document.getElementsByTagName('script')[0];
			scpt.parentNode.insertBefore(elem, scpt);
		})();

		_qevents.push({
			qacct:"p-v03RmX3GES6RT"
		});
	});


</script>

<script>
	fireOrSaveJsFunctions(1,function() {

		window._comscore = window._comscore || [];
		window._comscore.push({ c1: "2", c2: "19983957" });
		(function() {
			var s = document.createElement("script"), el = document.getElementsByTagName("script")[0]; s.async = true;
			//s.src = (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js";
			s.src = "https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/beacon.js";
			el.parentNode.insertBefore(s, el);
		})();

	})

</script>
<noscript>
  <img class="no_js" src="https://sb.scorecardresearch.com/p?c1=2&c2=19983957&cv=2.0&cj=1" />
</noscript>

<script>


	fireOrSaveJsFunctions(1,function() {

		!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
			n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
			n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
			t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
			document,'script','https://connect.facebook.net/en_US/fbevents.js');

		fbq('init', '1039134266174910');
		fbq('track', "PageView");

		fbq('track', 'ViewContent');

	});


</script>

<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=1039134266174910&ev=PageView&noscript=1"
/></noscript>

<!-- Source: /controltag?confid=qqeynsltk&site=medical%20news%20today&edit=1 -->
<script class="kxct" data-id="qqeynsltk" data-timing="async" data-version="1.9" type="text/javascript">
	fireOrSaveJsFunctions(1,function() {
		window.Krux || ((Krux = function () {
			Krux.q.push(arguments)
		}).q = []);
		(function () {
			var k = document.createElement('script');
			k.type = 'text/javascript';
			k.async = true;
			var m, src = (m = location.href.match(/\bkxsrc=([^&]+)/)) && decodeURIComponent(m[1]);
			k.src = /^https?:\/\/([a-z0-9_\-\.]+\.)?krxd\.net(:\d{1,5})?\//i.test(src) ? src : src === "disable" ? "" :
			(location.protocol === "https:" ? "https:" : "http:") + "//cdn.krxd.net/controltag?confid=qqeynsltk";
			var s = document.getElementsByTagName('script')[0];
			s.parentNode.insertBefore(k, s);
		}());
	});
</script>


<!-- Hotjar Tracking Code for https://www.medicalnewstoday.com/ -->
<script>
	(function(h,o,t,j,a,r){
		h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
		h._hjSettings={hjid:1295463,hjsv:6};
		a=o.getElementsByTagName('head')[0];
		r=o.createElement('script');r.async=1;
		r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
		a.appendChild(r);
	})(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
</script>
<script type="text/javascript"> window.jstag=function(){function t(t){return function(){return t.apply(this,arguments),this}}function n(){var n=["ready"].concat(c.call(arguments));return t(function(){n.push(c.call(arguments)),this._q.push(n)})}var i={_q:[],_c:{},ts:(new Date).getTime(),ver:"2.0.0"},c=Array.prototype.slice;return i.init=function(t){return i._c=t,t.synchronous||i.loadtagmgr(t),this},i.loadtagmgr=function(t){var n=document.createElement("script");n.type="text/javascript",n.async=!0,n.src=t.url+"/api/tag/"+t.cid+"/lio.js";var i=document.getElementsByTagName("script")[0];i.parentNode.insertBefore(n,i)},i.ready=n(),i.send=n("send"),i.mock=n("mock"),i.identify=n("identify"),i.pageView=n("pageView"),i.bind=t(function(t){i._q.push([t,c.call(arguments,1)])}),i.block=t(function(){i._c.blockload=!0}),i.unblock=t(function(){i._c.blockload=!1}),i}(),window.jstag.init({cid:"107d418c4b7bb3debf57a3af0ce16190", url:"//c.lytics.io", min:true, loadid:false}); </script>

<!-- Facebook Pixel Code -->
<script>

	fireOrSaveJsFunctions(1,function() {

		!function (f, b, e, v, n, t, s) {
			if (f.fbq)return;
			n = f.fbq = function () {
				n.callMethod ?
					n.callMethod.apply(n, arguments) : n.queue.push(arguments)
			};
			if (!f._fbq)f._fbq = n;
			n.push = n;
			n.loaded = !0;
			n.version = '2.0';
			n.queue = [];
			t = b.createElement(e);
			t.async = !0;
			t.src = v;
			s = b.getElementsByTagName(e)[0];
			s.parentNode.insertBefore(t, s)
		}(window,
			document, 'script', 'https://connect.facebook.net/en_US/fbevents.js');

		fbq('init', '1039134266174910');
		fbq('track', "PageView");
	});
</script>

<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=1039134266174910&ev=PageView&noscript=1"
/></noscript>



<!--Moat content code-->
<script>

	fireOrSaveJsFunctions(1,function(){

		(function(){function t(){for(var a=[8],e=1;2>=e;e++)a.push(8+e),a.push(8-e);a=a[Math.floor(Math.random()*a.length)];return{b:a,a:0==Math.floor(Math.random()*a)}}function k(a){var e=a=a.replace(":","");try{for(var b=0;100>b&&(a=decodeURIComponent(a),e!=a)&&!a.match(/^http(s)?\:/);b++)e=a}catch(c){}return a.replace(/(^\s+|\s+$)/g,"")}try{if(!location||!location.hostname||!location.pathname)return!1;var c=document.location.hostname.replace(/^www\./,""),u=function(){for(var a,b=document.getElementsByTagName("meta"),c,d=0,f=b.length;d<f;d++)if(c=b[d],"og:title"===c.getAttribute("property")){a=c.getAttribute("content");break}a||(a=document.title||"Untitled");return a}(),b={},b=function(a,b,c){a.l1=b;a.l2=c;a.l3="__page__";a.l4="-";return a}(b,c,u),l=(new Date).getTime(),m=Math.floor(Math.random()*Math.pow(10,12)),d,f;f=t();f.a?d=f.b:d=0;b.zmoatab_cm=d;b.t=l;b.de=m;b.zMoatAB_SNPT=!0;var g;d?g=d:g=1;var n;n=f?f.a?!0:!1:!0;var c=[],p=[k(b.l1),k(b.l2),k(b.l3),k(b.l4)].join(":"),v="https://wve3oiypgri4-a.akamaihd.net/z.gif?e=17&d="+
			encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&mp=1&ac=1&pl=1&bq=10&vc=2&cs=0",w="https://px.moatads.com/pixel.gif?e=17&d="+encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&mp=0&ac=1&pl=1&bq=10&ad_type=img&vc=2&cs=0",x="https://px.moatads.com/pixel.gif?e=17&d="+encodeURIComponent(p)+"&de="+m+"&t="+l+"&i=HEALTHLINECONTENT1&cm="+g+"&ku=1&ac=1&pl=1&bq=10&ad_type=img&vc=2&cs=0";n&&((new Image).src=v,(new Image).src=w);for(var q in b)c.push(q+"="+encodeURIComponent(b[q]));
			var c=c.join("&"),c=c+"&vc=2",h=document.createElement("script");h.type="text/javascript";h.async=!0;n&&(h.onerror=function(){(new Image).src=x});var r=document.getElementsByTagName("script")[0];r.parentNode.insertBefore(h,r);h.src="https://z.moatads.com/healthlinecontent451781663455/moatcontent.js#"+c}catch(a){try{var y="//pixel.moatads.com/pixel.gif?e=24&d=data%3Adata%3Adata%3Adata&i=MOATCONTENTABSNIPPET1&vc=2&ac=1&k="+encodeURIComponent(a)+"&j="+encodeURIComponent(document.referrer)+"&cs="+(new Date).getTime();
			(new Image).src=y}catch(e){}}})();


	});

</script>
</head>
<body id="drugs" class="article v2 tabbed lang_en">
<div itemscope="" itemtype="http://schema.org/NewsArticle">








<noscript>
<div class="header_message enable_js error">
<p>For full functionality, it is necessary to enable JavaScript. Here are <a href="http://www.enable-javascript.com" rel="noopener noreferrer" target="_blank">instructions how to enable JavaScript</a> in your web browser.</p>
</div>


<div class="fullscreen_outer">
	<div class="fullscreen_inner">
		<h5>Welcome to Medical News Today</h5>
		<p>
			Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a <a href="https://www.medicalnewstoday.com/privacy-policy#vendors" target="_blank">current list</a>) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.</p>
		<p>
			Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.
		</p>
		<p>
			By clicking “accept” below, you acknowledge and grant your consent for these activities unless and until you withdraw your consent using our <a href="https://www.healthline.com/rights-request" rel="noopener noreferrer" target="_blank">rights request form</a>. Learn more in our <a href="https://www.medicalnewstoday.com/privacy-policy" target="_blank">Privacy Policy</a>.
		</p>
	</div>
</div>


</noscript>
<div id="header_message" class="new_menu">
<input type="hidden" id="is_usermobile" name="is_usermobile" value="0">





 
</div>

<div id="navigation" class="container default_menu new_menu">

	<div class="row">

		<nav role="navigation" class="main_nav">
		
			<ul class="main_nav left"> 	
				<li class="menu_topics">
					<a href="#"></a>
		
					
<div class="menu_panel fullscreen_outer topics">
  <div class="menu_panel fullscreen_inner">
    <div class="row">
					
					
					<div class="topics">
												
							<div class="menu_topic_container">
							
								<ul class="topic_headings">
									<li class="topic_headings_top"><span>Top categories</span>
										<ul class="topic_popular_list">
											<li><a href="/categories/blood">Blood / Hematology</a></li>
<li><a href="/categories/bones">Bones / Orthopedics</a></li>
<li><a href="/categories/breast_cancer">Breast Cancer</a></li>
<li><a href="/categories/colorectal_cancer">Colorectal Cancer</a></li>
<li><a href="/categories/depression">Depression</a></li>
<li><a href="/categories/gastrointestinal">GastroIntestinal</a></li>
<li><a href="/categories/hypertension">Hypertension</a></li>
<li><a href="/categories/lymphoma">Lymphoma</a></li>
<li><a href="/categories/mens_health">Men's Health</a></li>
<li><a href="/categories/neurology">Neurology / Neuroscience</a></li>
<li><a href="/categories/nutrition-diet">Nutrition / Diet</a></li>
<li><a href="/categories/pain">Pain / Anesthetics</a></li>
<li><a href="/categories/prostate">Prostate / Prostate Cancer</a></li>
<li><a href="/categories/psoriasis">Psoriasis</a></li>
<li><a href="/categories/respiratory">Respiratory</a></li>
<li><a href="/categories/sexual_health">Sexual Health / STDs</a></li>
<li><a href="/categories/stroke">Stroke</a></li>
<li><a href="/categories/tuberculosis">Tuberculosis</a></li>
<li><a href="/categories/urology-nephrology">Urology / Nephrology</a></li>
<li><a href="/categories/womens_health">Women's Health</a></li>
										</ul> 	
									</li>
																											
									<li class="topic_headings_all"><span>All categories</span>
										<ul class="topic_all_list">
											<li><a href="/categories#a">A - B</a></li>
											<li><a href="/categories#c">C - D</a></li>
											<li><a href="/categories#e">E - G</a></li>
											<li><a href="/categories#h">H - L</a></li>
											<li><a href="/categories#m">M - O</a></li>
											<li><a href="/categories#p">P - R</a></li>
											<li><a href="/categories#s">S - Z</a></li>
											<li><a href="/categories">All Topics</a></li>
										</ul>	
									</li>


								</ul> 									
							</div> 	
						
							<div class="menu_cta_container">
							
									<span>More</span>	
																		
									<ul class="topic_more_list">
										<li class="menu_newsletter_cta"><a href="#" class="new_reg_signup menu_item_link" data-signup-source="menu_item_link"><span class="icon_container"></span>Sign up for our newsletter</a></li>
										<li class="menu_discover_cta"><a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-menu-cta-2017.png" height="15" width ="34"/>Discover in-depth, condition specific articles written by our in-house team.</a></li>

									</ul> 	
	
							</div> 	
			
			
											
					</div> 	
					</div> 	
					</div> 	
											
											
											
					</div> 	
			  
				</li> 	

					<li class="menu_newsletter">

						<a href="#" data-signup-source="menu_newsletter_link" class="menu-newsletter-link  new_reg_signup"><div>Newsletter</div></a>

					</li> 	

			</ul>
				
			<div class="logo">
				<a href="/" accesskey="h" title="Medical News Today : Home">
					<img src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-2017-640-60.png" alt="MNT home">
					<p>MNT - Hourly Medical News Since 2003</p>
				</a>
			</div> 	
				
			<ul class="main_nav right"> 	

			<div id="search_area">


<div id="searchwrapper" class="">



<div class="search_trigger">

<form id="searchFormHeader" action="/search" >
<input type="text" id="header_search" placeholder="" class="searchbox" name="q" maxlength="150" autocomplete="off"/>
<button class="screen_only black float_right" id="header_search_button" type="submit" id="" title="Search MNT" value="">Search</button>
<button class="mobile_only blue float_right" id="header_search_button" type="submit" title="Search MNT" value="">Go</button>
<input type="hidden" name="p" value="1" />
</form>



</div>
	

</div>
</div>	
			


					<li class="menu_login">
						<a href="#" id="menu_login_link">
							<div>

							</div>
						</a>
					</li>
			</ul>
		</nav>	

	</div> 	

</div> 
<div id="navigation_scroll" class="container light  ">

<div class="row">

<nav id="subnavigation">

			<ul class="main_nav left"> 	
				<li class="menu_topics">
					<a href="#"></a>
		
					
<div class="menu_panel fullscreen_outer topics">
  <div class="menu_panel fullscreen_inner">
    <div class="row">
					
					
					<div class="topics">
												
							<div class="menu_topic_container">
							
								<ul class="topic_headings">
									<li class="topic_headings_top"><span>Top categories</span>
										<ul class="topic_popular_list">
											<li><a href="/categories/blood">Blood / Hematology</a></li>
<li><a href="/categories/bones">Bones / Orthopedics</a></li>
<li><a href="/categories/breast_cancer">Breast Cancer</a></li>
<li><a href="/categories/colorectal_cancer">Colorectal Cancer</a></li>
<li><a href="/categories/depression">Depression</a></li>
<li><a href="/categories/gastrointestinal">GastroIntestinal</a></li>
<li><a href="/categories/hypertension">Hypertension</a></li>
<li><a href="/categories/lymphoma">Lymphoma</a></li>
<li><a href="/categories/mens_health">Men's Health</a></li>
<li><a href="/categories/neurology">Neurology / Neuroscience</a></li>
<li><a href="/categories/nutrition-diet">Nutrition / Diet</a></li>
<li><a href="/categories/pain">Pain / Anesthetics</a></li>
<li><a href="/categories/prostate">Prostate / Prostate Cancer</a></li>
<li><a href="/categories/psoriasis">Psoriasis</a></li>
<li><a href="/categories/respiratory">Respiratory</a></li>
<li><a href="/categories/sexual_health">Sexual Health / STDs</a></li>
<li><a href="/categories/stroke">Stroke</a></li>
<li><a href="/categories/tuberculosis">Tuberculosis</a></li>
<li><a href="/categories/urology-nephrology">Urology / Nephrology</a></li>
<li><a href="/categories/womens_health">Women's Health</a></li>
										</ul> 	
									</li>
																											
									<li class="topic_headings_all"><span>All categories</span>
										<ul class="topic_all_list">
											<li><a href="/categories#a">A - B</a></li>
											<li><a href="/categories#c">C - D</a></li>
											<li><a href="/categories#e">E - G</a></li>
											<li><a href="/categories#h">H - L</a></li>
											<li><a href="/categories#m">M - O</a></li>
											<li><a href="/categories#p">P - R</a></li>
											<li><a href="/categories#s">S - Z</a></li>
											<li><a href="/categories">All Topics</a></li>
										</ul>	
									</li>

								</ul> 									
							</div> 	
						
							<div class="menu_cta_container">
							
									<span>More</span>	
																		
									<ul class="topic_more_list">

										<li class="menu_newsletter_cta"><a href="#" class="new_reg_signup menu_item_link" data-signup-source="menu_item_link"><span class="icon_container"></span>Sign up for our newsletter</a></li>
										<li class="menu_discover_cta"><a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-menu-cta-2017.png" height="15" width ="34"/>Discover in-depth, condition specific articles written by our in-house team.</a></li>

									</ul> 	
	
							</div> 	
			
			
											
					</div> 	
					</div> 	
					</div> 	
											
											
											
					</div> 	
			  
				</li> 

					<li class="menu_newsletter">

						<a href="#" data-signup-source="menu_newsletter_link" class="menu-newsletter-link  new_reg_signup"><div>Newsletter</div></a>

					</li> 
				
			</ul>
				
			<div class="logo">
				<a href="/" accesskey="h" title="Medical News Today : Home">
					<img src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-2017-640-60.png" alt="MNT home">
					<p>MNT - Hourly Medical News Since 2003</p>
				</a>
			</div> 	
				
			<ul class="main_nav right"> 	
				
					

			<div id="search_area">


<div id="searchwrapper" class="">



<div class="search_trigger">

<form id="searchFormHeader" action="/search" >
<input type="text" id="header_search" placeholder="" class="searchbox" name="q" maxlength="150" autocomplete="off"/>
<button class="screen_only black float_right" id="header_search_button" type="submit" id="" title="Search MNT" value="">Search</button>
<button class="mobile_only blue float_right" id="header_search_button" type="submit" title="Search MNT" value="">Go</button>
<input type="hidden" name="p" value="1" />
</form>



</div>
	

</div>
</div>	
			


					<li class="menu_login">
						<a href="#" id="menu_login_link">
							<div>

							</div>
						</a>

					</li>
			</ul>
		
		</nav>	

	</div> 	

</div> <div class="modal fade" id="picModal" tabindex="-1" role="dialog" style="z-index: 1040; padding-left:0;">
	<div class="modal-dialog" role="document">
		<div class="modal-content" style="">
			<div class="modal-header">
				<button type="button" class="close" data-dismiss="modal" aria-label="Close"></button>

			</div>
			<div class="modal-body" style="text-align: center;">

				<div id="picModal-loading-animation">

					<i class="fa fa-circle-o-notch fa-spin fa-3x fa-fw"></i>
					<span class="sr-only">Loading...</span>

				</div>


				<span class="helper" style="display: inline-block;height: 100%;vertical-align: middle;"></span> <img id="origin-img" src="">

			</div>

		</div>
	</div>
</div>


<div class="modal fade site_modal modal_gdpr" tabindex="-1" role="dialog" aria-hidden="true" id="gdprModal" data-backdrop="static" data-keyboard="false">
	<div class="modal-dialog" role="document">

		<div class="modal-content">

			<div class="modal-header">
			</div>

			<div class="modal-body container" onscroll="modalScroll()">
				<div class="fullscreen_outer article_header">
					<div class="fullscreen_inner">
						<h5>Please accept our privacy terms</h5>
						<p>
							We use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. We may share your information with third-party partners for marketing purposes. To learn more and make choices about data use, visit our <a href="https://www.medicalnewstoday.com/advertising" target="_blank">Advertising Policy</a> and <a href="https://www.medicalnewstoday.com/privacy-policy" target="_blank">Privacy Policy</a>. By clicking “Accept and Continue” below, (1) you consent to these activities unless and until you withdraw your consent using our rights request form, and (2) you consent to allow your data to be transferred, processed, and stored in the United States.
						</p>
					</div>
				</div>
			</div>
			<div class="modal-footer container gradient">
				<div class="article_header">
					<button class="primary" onclick="GDPRAccept()">ACCEPT AND CONTINUE TO SITE</button>
					<button class="secondary" onclick="confirmDeny()">Deny permission</button>
				</div>
			</div>

		</div>
		<div class="scroll_more hidden">
			<button class="primary" onclick="scrollAccept()">Scroll to Accept</button>
		</div>

	</div>
</div>



	<!--for new newsletter sign up proc-->
	<div class="modal fade registration_modal_form" tabindex="-1" role="dialog" aria-hidden="true" id="registrationModal">
		<div class="modal-dialog" role="document">
			<div class="modal-content modal_reg" id="registration_modal_form">
									<div class="modal-header screen_only">
						<h4 class="modal-title">Get the MNT newsletter</h4>
						<button type="button" class="close" data-dismiss="modal"></button>
					</div>
				


				<div class="modal-body" id="registration_start">

					<div class="iframe_scroll_container">

						<!--form migration start-->

						<form id="new-reg-form">
							<div class="form container_reg">
								<div class="form header_reg">

									<div class="form-group">
										<input type="email" name="formEmail" style="margin-bottom: 20px;" class="form-control newsletterFormEmail" id="inputEmail" placeholder="Enter email address" value="">
									</div>

									<!--error meesage place holder-->
									<div id="signFinishErrorHolder" class="errorHolder"></div>


									<div id="registration_modal_message" class="form-group">


										<!--while user finish the register process, something info need to tell user, but not error message-->
										<div id="newsletterRegisterInfo" class="message start">

										</div>


										<!--User will see the message everytime open the register modal-->
										<div id="newsletterTypeMessage" class="message start">

											<p>
												Enter your email address to subscribe to <span id="selectedCategoryText">our most top categories</span>
											</p>

											

<p>Your <a href="/privacy-policy" title="Privacy policy">privacy</a> is important to us.</p>

										</div>

									</div>

								</div>
							</div>

							<!--set by js-->
							<input type="hidden" id="newsletterCategories" name="newsletterCategories" value="">
							<input type="hidden" id="newsletterTypeMessageHTMLBackup" name="newsletterTypeMessageHTMLBackup" value="">

						</form>

						<!--form migration end-->

					</div>
				</div>


				<div class="modal-footer">
					<button type="button" id="email-start-signup-btn" class="btn btn-success btn-block">CONTINUE</button>

<!--					<button type="button" id="email-finish-signup-btn" class="btn btn-danger btn-block" data-dismiss="modal">OK</button>-->
				</div>				

			</div>



		</div><!-- /.modal-dialog -->
	</div><!-- /.modal -->



<div class="modal fade email-an-article-modal" tabindex="-1" role="dialog" aria-hidden="true" id="email-an-article-modal">
	<div class="modal-dialog" role="document">
		<div class="modal-content">
			<div class="modal-header">
				<h3 class="">Email an article</h3>
				<button type="button" class="close" data-dismiss="modal"></button>
			</div>
			<div class="modal-body">
				<p>You have chosen to share the following article:</p>
				<p><b id="email-an-article-title">How elderberries can help you fight the flu</b></p>
				<p>To proceed, simply complete the form below, and a link to the article will be sent by email on your behalf.<br>
					<b>Note:</b> Please don't include any URLs in your comments, as they will be removed upon submission.</p>
				<p>We do not store details you enter into this form. Please see our <a href="/privacy-policy" title="Read our Privacy Policy" target="_blank">privacy policy</a> for more information.</p>

				<form id="email-an-article-form">
					<fieldset class="form-container">
						<div>
							<label><em>*</em>Your Name (max. 30 chars)</label>
							<input id="fromName" type="text" name="fromName" maxlength="30" value="" required>
							<label for="fromName" generated="true" class="formError" style="display: none">The field 'Your Name' is required.</label>
						</div>
						<div>
							<label><em>*</em>Email Address</label>
							<input id="fromEmailAddress" class="formEmail" type="email" name="fromEmailAddress" maxlength="100" value="" required>
							<label for="fromEmailAddress" generated="true" class="formError" style="display: none">This is not a valid email address.</label>
						</div>
						<div>
							<label><em>*</em>Friend's Name (max. 30 chars)</label>
							<input id="toName" type="text" name="toName" maxlength="30" value="" required>
							<label for="toName" generated="true" class="formError" style="display: none">The field 'Friend's Name' is required.</label>
						</div>
						<div>
							<label><em>*</em>Friend's Email Address</label>
							<input id="toEmailAddress" type="email" name="toEmailAddress" maxlength="100" value="" required>
							<label for="toEmailAddress" generated="true" class="formError" style="display: none">The field 'Friend's Email Address' is required.</label>
						</div>

					</fieldset>


					<div id="email-an-article-reCAPTCHA" class="g-recaptcha" data-sitekey="6Le68KEUAAAAAOKVyWLvP5U0Dl2HT9dqR0J1hx7z"></div>




					<div class="buttonrow">
						<button type="submit" id="email_submit" class="btn-form form-submit secure">Send securely</button>
						<span class="form_secure_icon"></span>
					</div>

				</form>

				<div class="robots-nocontent">
					<div id="email-an-article-success" class="information"  style="display: none">
						<h2 class="message_box">Message sent successfully</h2>
						<p><b>The details of this article have been emailed on your behalf.</b></p>
						<p><a href="/" title="Click here to return to the MNT homepage">Click here</a> to return to the Medical News Today home page.</p>
					</div>
				</div>
			</div>
		</div>
	</div><!-- /.modal-dialog -->
</div>










<hr class="css_h1ksn" >






<div class="container"> 

<div class="row site_header"> 

<article  >

			<div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 article_header"> 		<!-- Leaderboard BANNER advert -->

<div id="dlb1_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb1_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB1',
			"slotContainer":'dlb1_container'		});
	</script>
	</div>
	<span class='bt-uid-tg' data-uid='5b84646203-160' style='display: none !important' data-style='width: 728px;height: 90px;background: rgba(255, 255, 255, 0.5);border: 2px solid #888;box-sizing: border-box;margin: 0 auto 0;'></span>

</div>






<!-- /header_ad code -->
<h1 itemprop="headline">Afinitor (everolimus)</h1>

</div> 	<div class="col-xs-12 col-sm-12 col-md-8 col-lg-8 main_content"> 	<div id="article_date">
			<span class="date_reviewed screen_only">Last reviewed		<time itemprop="lastReviewed" datetime="2019-05-23">
		Thu 23 May 2019		</time></span>
		
		<span class="date_reviewed mobile_only">Last reviewed		Thu 23 May 2019</span>
		
			</div>
		<div class="author_top">
	<span class='author_byline'>By Victor Nguyen, PharmD, MS</span>	</div>
				<div class="reviewer_top">
			<span class='reviewer_byline'>Reviewed by <a href='/reviewers' class='article_author' rel='author' title='MNT medical review team' >Catherine C. Peng, PharmD, BCPS</a></span>			</div>
			<span class="clearfix"></span>

<div class="article_body">
	<div itemprop="articleBody">
	<div class="article_toc collapsed article_collapsed">
<a class="collapsed__click" href="#"><i class="collapsed__icon"></i>Table of contents</a><ol class="collapsed__tabs hide">
<li><a href="#generic">Generic</a></li>







<li><a href="#side-effects">Side effects</a></li>







<li><a href="#dosage">Dosage</a></li>







<li><a href="#cost">Cost</a></li>







<li><a href="#uses">Uses</a></li>







<li><a href="#use-with-other-drugs">Use with other drugs</a></li>







<li><a href="#afinitor-and-alcohol">Afinitor and alcohol</a></li>







<li><a href="#interactions">Interactions</a></li>







<li><a href="#alternatives">Alternatives</a></li>







<li><a href="#afinitor-vs-ibrance">Afinitor vs. Ibrance</a></li>







<li><a href="#how-to-take">How to take</a></li>







<li><a href="#how-it-works">How it works</a></li>







<li><a href="#pregnancy">Pregnancy</a></li>







<li><a href="#breastfeeding">Breastfeeding</a></li>







<li><a href="#faqs">FAQs</a></li>







<li><a href="#warnings">Warnings</a></li>







<li><a href="#overdose">Overdose</a></li>







<li><a href="#expiration">Expiration</a></li>







<li><a href="#for-professionals">For professionals</a></li>







</ol>
</div>







<h2>What is Afinitor?</h2>







<p>Afinitor is a brand-name prescription medication that's used to treat certain types of <a href="/info/cancer-oncology/" title="What is Cancer?" class="keywords">cancers</a>, tumors, and seizures. It contains the drug everolimus.</p>







<p>Afinitor is a type of drug called a mammalian target of rapamycin (mTOR) inhibitor. mTORs are targeted therapies that work by "targeting" and attacking cancer cells. Afinitor is not considered <a href="/articles/158401.php" title="What you need to know about chemotherapy" class="keywords">chemotherapy</a>, which acts on all cells in the body that are growing quickly, not just cancer cells.</p>







<p>Afinitor is available in two forms:</p>







<ul>
<li>
<strong>Afinitor</strong> comes as a tablet that you swallow.</li>







<li>
<strong>Afinitor Disperz</strong> comes as a tablet for oral suspension. You dissolve the tablet in a liquid, which you then swallow.</li>







</ul>
<h3>What it does</h3>







<p>Afinitor is approved to treat several types of cancers and tumors:</p>







<ul>
<li>
<strong>Advanced hormone receptor-positive</strong>, HER2-negative <a href="/articles/37136.php" title="What to know about breast cancer" class="keywords">breast cancer</a> in women who have gone through <a href="/articles/155651.php" title="Everything you need to know about menopause" class="keywords">menopause</a> and have already tried letrozole (Femara) or anastrozole (Arimidex). Afinitor for breast cancer is to be used with the anticancer drug exemestane (Aromasin).</li>







<li>
<strong>Advanced renal cell carcinoma</strong> (<a href="/articles/164659.php" title="What you need to know about kidney cancer" class="keywords">kidney cancer</a>) in adults who have already tried the anticancer drugs sunitinib (Sutent) or sorafenib (Nexavar).</li>







<li>
<strong>Neuroendocrine tumors in the pancreas</strong>, lungs, or stomach and gut in adults that cannot be treated by surgery.</li>







<li>
<strong>Renal angiomyolipoma</strong>, a type of benign (not cancerous) kidney <a href="/articles/249141.php" title="What are the different types of tumor?" class="keywords">tumor</a>, in adults with the genetic disorder tuberous sclerosis.</li>







</ul>
<p>Afinitor Disperz is approved to treat:</p>







<ul>
<li>
<strong>partial seizures</strong> (also called focal onset seizures) in adults and children ages 2 years and older with tuberous sclerosis who are taking antiseizure drugs</li>







</ul>
<p>Both Afinitor and Afinitor Disperz are approved to treat:</p>







<ul>
<li>
<strong>subependymal giant cell astrocytoma (SEGA)</strong>, a type of benign (not cancerous) brain tumor in adults and children ages 1 year and older with tuberous sclerosis</li>







</ul>
<span class="anchor" id="generic"></span>
<h2>Afinitor generic</h2>







<p>Afinitor is available only as a brand-name medication. It doesn't currently have a generic form.</p>







<p>Afinitor contains the drug everolimus. Everolimus is also available as the brand-name drug Zortress, which is used to prevent organ rejection after an organ transplant.</p>







<span class="anchor" id="side-effects"></span>
<h2>Afinitor side effects</h2>







<p>Afinitor can cause mild or serious side effects. The following list contains some of the key side effects that may occur while taking Afinitor. This list does not include all possible side effects.</p>







<p>For more information on possible side effects of Afinitor, talk with your doctor or pharmacist. They can also give you tips on how to deal with a bothersome side effect.</p>







<h3>More common side effects</h3>







<p>The more common side effects of Afinitor can include:</p>







<ul>
<li>stomatitis (sores or swelling in your mouth)</li>







<li>increased risk of infections</li>







<li>rash</li>







<li><a href="/articles/158634.php" title="What you should know about diarrhea" class="keywords">diarrhea</a></li>







<li>swelling of your hands, arms, feet, ankles, or legs</li>







<li>pain in your abdomen (belly)</li>







<li>nausea</li>







<li>vomiting</li>







<li><a href="/articles/168266.php" title="Fever: What you need to know" class="keywords">fever</a></li>







<li>weakness or lack of energy</li>







<li>cough</li>







<li><a href="/articles/73936.php" title="What is causing this headache?" class="keywords">headache</a></li>







<li>loss of appetite</li>







<li>weight loss</li>







<li>metabolic syndrome</li>







</ul>
<p>Most of these side effects may go away within a few days or a couple of weeks. If they're more severe or don't go away, talk with your doctor or pharmacist.</p>







<h3>Serious side effects</h3>







<p>Serious side effects from Afinitor can occur. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency. Serious side effects can include the following:</p>







<ul>
<li>allergic reaction</li>







<li>pneumonitis (swelling in your lungs that's not caused by an infection)</li>







<li>infections</li>







<li>
<a href="/articles/216095.php" title="Everything you need to know about angioedema" class="keywords">angioedema</a> (swelling under your skin, typically in your eyelids, lips, hands, or feet)</li>







<li>kidney failure</li>







<li>myelosuppression (when <a href="/articles/285666.php" title="All you need to know about bone marrow" class="keywords">bone marrow</a> makes fewer blood cells)</li>







</ul>
<p>See the "Side effect details" section below for symptoms of these conditions.</p>







<h3>Side effect details</h3>







<p>You may wonder how often certain side effects occur with this drug. Here's some detail on certain side effects this drug may cause.</p>







<p><strong>Allergic reaction</strong></p>







<p>As with most drugs, some people can have an allergic reaction after taking Afinitor. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical trials</a>, 3% of people who took Afinitor had an allergic reaction. Symptoms of a mild allergic reaction can include:</p>







<ul>
<li>skin rash</li>







<li>itchiness</li>







<li>flushing (warmth and redness in your skin)</li>







</ul>
<p>A more severe allergic reaction is rare, but possible. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical trials</a>, up to 1% of people taking Afinitor had a severe allergic reaction. Symptoms of a severe allergic reaction can include:</p>







<ul>
<li>angioedema (swelling under your skin, typically in your eyelids, lips, hands, or feet)</li>







<li>swelling of your tongue, mouth, or throat</li>







<li>trouble breathing</li>







</ul>
<p>Call your doctor right away if you have a severe allergic reaction to Afinitor. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>







<p><strong>Rash</strong></p>







<p>Rash is one of the most common side effects of Afinitor. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, rash occurred in up to 59% of people using Afinitor. You may be having an allergic reaction to Afinitor if:</p>







<ul>
<li>you have a rash that doesn't go away after a couple days</li>







<li>you have chest pains or trouble breathing or swallowing</li>







</ul>
<p>Call your doctor right away if you have a severe allergic reaction to Afinitor. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>







<p><strong>Pneumonitis</strong></p>







<p>Afinitor is a type of drug called a mammalian target of rapamycin (mTOR) inhibitor. A possible side effect of this type of drug is noninfectious pneumonitis. This is <a href="/articles/248423.php" title="Everything you need to know about inflammation" class="keywords">inflammation</a> (swelling) of the lungs that's not caused by an infection. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, up to 19% of people who took Afinitor had noninfectious pneumonitis.</p>







<p>Symptoms of pneumonitis can include:</p>







<ul>
<li>shortness of breath</li>







<li>cough</li>







<li><a href="/articles/248002.php" title="Fatigue: Why am I so tired and what can I do about it?" class="keywords">fatigue</a></li>







</ul>
<p>If you start having symptoms of pneumonitis, call your doctor right away. Your doctor may change your dose of Afinitor or have you stop taking it.</p>







<p><strong>Hair loss</strong></p>







<p><a href="/articles/70956.php" title="What's to know about alopecia areata?" class="keywords">Hair loss</a> typically doesn't occur with use of Afinitor alone. However, it can occur when Afinitor is used with a drug called exemestane.</p>







<p>Hair loss is common in people who take exemestane. In one <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf066b7a-032a-416c-8d40-15ba581423e3" target="_blank" rel="noopener">clinical study</a>, 15% of people who took exemestane alone had hair loss.</p>







<p>In another <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">study</a>, 10% of people treated with Afinitor and exemestane for breast cancer had hair loss.</p>







<p>It's important to note that hair loss was only seen when Afinitor was given with exemestane. People who took Afinitor alone didn't experience hair loss.</p>







<p>Typically, hair loss from use of exemestane isn't permanent. Your hair should start to grow back weeks after your treatment ends. If you're concerned about hair loss, talk with your doctor.</p>







<p><strong>Infections</strong></p>







<p>Drugs that treat cancer, such as Afinitor, can weaken your body's immune system. This can put you at increased risk for infections. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, up to 58% of people who took Afinitor had an infection, and up to 10% had a severe infection.</p>







<p>Symptoms of severe infections can include:</p>







<ul>
<li>high fever</li>







<li>shivering</li>







<li>rapid heart rate</li>







<li>confusion</li>







<li>shortness of breath</li>







<li>pain or discomfort</li>







<li>sweating</li>







</ul>
<p>If you start having symptoms of an infection while taking Afinitor, talk with your doctor. They may change your dosage or have you stop taking the medication. They may need to prescribe medication to treat your infection. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>







<p><strong>Kidney failure</strong></p>







<p>There have been reports of kidney failure in people treated with Afinitor. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, up to 2% of people had high levels of serum creatinine, which measures your kidney health. Also, 1% had proteinuria (high levels of protein in urine), which may be a sign of kidney damage.</p>







<p>Also in these studies, 3% of people with kidney cancer developed kidney failure. And nearly 3% of people with <a href="/info/pancreatic-cancer/" title="What is Pancreatic Cancer?" class="keywords">pancreatic cancer</a> had severe kidney failure.</p>







<p>Before and during your treatment with Afinitor, your doctor will track how well your kidneys are working. This is very important if you're at risk for kidney disease.</p>







<p>Symptoms of kidney failure can include:</p>







<ul>
<li>urinating less</li>







<li>swelling in your legs, ankles, or feet</li>







<li>shortness of breath</li>







<li>confusion</li>







<li>fatigue</li>







<li>nausea</li>







<li>chest pain or pressure</li>







<li>irregular heartbeat</li>







<li>seizures</li>







</ul>
<p>Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>







<p>If you have a history of kidney problems, talk with your doctor before taking Afinitor.</p>







<p><strong>Myelosuppression</strong></p>







<p>Myelosuppression is a common side effect of taking Afinitor. With this condition, bone marrow makes fewer blood cells. This can decrease the number of your red blood cells, white blood cells, and platelets.</p>







<p>In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, as many as 86% of people who took Afinitor had <a href="/articles/158800.php" title="Everything you need to know about anemia" class="keywords">anemia</a> (low red blood cell count). Severe anemia, which requires medical treatment such as a blood transfusion, occurred in up to 15% of people who took Afinitor.</p>







<p>Symptoms of anemia can include:</p>







<ul>
<li>fatigue</li>







<li>weakness</li>







<li>pale or yellowish skin</li>







<li>irregular heartbeat</li>







<li>shortness of breath</li>







<li>dizziness or lightheadedness</li>







<li>chest pain</li>







</ul>
<p>In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, up to 54% of people who took Afinitor had thrombocytopenia (a low platelet count). Up to 3% of those cases were severe. Severely low platelet counts put you at increased risk for having a bleed that requires medical treatment.</p>







<p>Symptoms of a low platelet count can include:</p>







<ul>
<li>easy bruising</li>







<li>longer wound heal time</li>







<li>bleeding from your gums or nose</li>







<li>blood in your urine or stool</li>







</ul>
<p>If you have a low white blood cell count (leukopenia), you may also develop infections. This is especially true if you have a low count of a certain type of white blood cell (neutropenia). In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical trials</a>, up to 46% of people who took Afinitor developed neutropenia. Up to 9% of cases were severe. Your risk of developing a serious infection is greater if your neutropenia is severe.</p>







<p>Symptoms of an infection can include:</p>







<ul>
<li>fever</li>







<li>chills</li>







<li>cough</li>







<li>swelling</li>







</ul>
<p>If you have symptoms of an infection while taking Afinitor, talk with your doctor. They may want to change your dose or stop taking the medication. They may also prescribe medication to treat the infection. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>







<p><strong>Metabolic syndrome</strong></p>







<p>Metabolic syndrome is a common side effect of taking Afinitor. With this condition, your blood sugar, <a href="/articles/9152.php" title="What causes high cholesterol?" class="keywords">cholesterol</a>, and triglyceride levels can spike while taking the drug.</p>







<p>In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, hyperglycemia (high blood sugar) was reported in up to 75% of people who took Afinitor. High cholesterol levels were reported in up to 86% of people. And high triglyceride levels were reported in up to 73% of people.</p>







<p>High cholesterol and high triglyceride levels don't normally cause symptoms. But they can increase your risk for chronic (long-term) diseases, such as <a href="/articles/237191.php" title="Everything you need to know about heart disease" class="keywords">heart disease</a>, over time.</p>







<p>Symptoms of high blood sugar can include:</p>







<ul>
<li>feeling more thirsty than normal</li>







<li>urinating more often than normal</li>







<li>urinating more often at night</li>







<li>blurry vision</li>







<li>sores that won't heal</li>







<li>fatigue</li>







</ul>
<p>Your doctor should monitor your blood sugar, cholesterol, and triglycerides levels before and during your Afinitor treatment. If you have <a href="/info/diabetes/" title="What is Diabetes?" class="keywords">diabetes</a>, you'll need to check your blood sugar levels more often.</p>







<h3>Side effects in children</h3>







<p>Infections, including serious infections, may be more common in people of all ages during Afinitor treatment. Two <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a> looked at children who took Afinitor. Children younger than age 6 years had higher rates of infection than children older than age 6.</p>







<p>One <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">study</a> looked at Afinitor use in children with certain conditions. These conditions were the genetic disorder tuberous sclerosis and a type of benign (not cancerous) brain tumor called subependymal giant cell astrocytoma (SEGA).</p>







<p>In this study, infections occurred in:</p>







<ul>
<li>96% of children younger than age 6 years</li>







<li>67% of children ages 6 years and older</li>







</ul>
<p>And serious infections occurred in:</p>







<ul>
<li>35% of children younger than age 6 years</li>







<li>7% of children ages 6 and older</li>







</ul>
<p>In another <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">study</a>, children with tuberous-sclerosis-related partial seizures took Afinitor in addition to other antiseizure drugs.</p>







<ul>
<li>In this study, infections occurred in:</li>







<ul>
<li>77% of children younger than age 6</li>







<li>53% of children ages 6 and older</li>







</ul>
<li>And serious infections occurred in:</li>







<ul>
<li>16% of children younger than age 6</li>







<li>4% of children ages 6 and older</li>







</ul>
</ul>
<span class="anchor" id="dosage"></span>
<!--[MMR]--><!--[END MMR]--><h2>Afinitor dosage</h2>







<div id="onequarter-of-article"></div>
<p>The Afinitor dosage your doctor prescribes will depend on several factors. These may include:</p>







<ul>
<li>the type of condition you're taking Afinitor to treat</li>







<li>your age</li>







<li>your <a href="/info/obesity/how-much-should-i-weigh.php" title="How Much Should I Weigh?" class="keywords">body weight</a>
</li>







<li>other medical conditions you may have</li>







<li>other drugs you may be taking</li>







<li>how severe your side effects are</li>







</ul>
<p>The following information describes dosages that are commonly used or recommended. <strong>However, be sure to take the dosage your doctor prescribes for you</strong>. Your doctor will determine the best dosage to suit your needs.</p>







<h3>Drug forms and strengths</h3>







<p>Afinitor comes in two forms:</p>







<ul>
<li>
<strong>Afinitor</strong> comes as a tablet that you swallow. It comes in four strengths:</li>







<ul>
<li>2.5 mg</li>







<li>5 mg</li>







<li>7.5 mg</li>







<li>10 mg</li>







</ul>
<li>
<strong>Afinitor Disperz</strong> comes as a tablet that you dissolve in a liquid, and then swallow. It comes in three strengths:</li>







<ul>
<li>2 mg</li>







<li>3 mg</li>







<li>5 mg</li>







</ul>
</ul>
<h3>Afinitor dosage for breast cancer</h3>







<p>For advanced hormone receptor-positive, HER2-negative breast cancer, the recommended starting dosage of Afinitor is 10 mg per day. If side effects become severe or your condition worsens, your doctor may change your dosage.</p>







<h3>Afinitor dosage for kidney cancer</h3>







<p>For advanced renal cell carcinoma (kidney cancer), the recommended starting dosage of Afinitor is 10 mg per day. If side effects become severe or your condition worsens, your doctor may change your dosage.</p>







<h3>Afinitor dosage for neuroendocrine tumors of the pancreas, lung, or stomach/gut</h3>







<p>For neuroendocrine tumors of the pancreas, lung, or stomach/gut, the recommended starting dosage of Afinitor is 10 mg per day. If side effects become severe or your condition worsens, your doctor may change the dosage.</p>







<h3>Afinitor dosage for kidney tumors</h3>







<p>For renal angiomyolipoma, a type of benign (not cancerous) kidney tumor, the recommended starting dosage of Afinitor is 10 mg per day. If side effects become severe or your condition worsens, your doctor may change the dosage.</p>







<h3>Afinitor or Afinitor Disperz dosage for brain tumors</h3>







<p>For subependymal giant cell astrocytoma (SEGA), a type of benign (not cancerous) brain tumor, the recommended starting dose of Afinitor is 4.5 mg per square meter of body surface area (BSA).</p>







<p>Your doctor will calculate your BSA and determine your dosage. They'll round it to the nearest dose to match a strength the drug comes in.</p>







<p>If side effects become severe or your condition worsens, your doctor may change the dosage.</p>







<h3>Afinitor Disperz dosage for seizures</h3>







<p>For partial seizures (also called focal onset seizures), the recommended starting dose of Afinitor Disperz is 5 mg per square meter of BSA.</p>







<p>Your doctor will calculate your BSA and determine your dosage. They'll round it to the nearest dose to match a strength the drug comes in.</p>







<p>If side effects become severe or your condition worsens, your doctor may change the dosage.</p>







<h3>Pediatric dosage</h3>







<p>For either SEGA or partial seizures in children, the recommended dosage of Afinitor or Afinitor Disperz is based on BSA. Your doctor will calculate your child's BSA and determine the dosage. They'll round it to the nearest dose to match a strength the drug comes in.</p>







<ul>
<li>For SEGA in children, the recommended dose of Afinitor or Afinitor Disperz is 4.5 mg per square meter.</li>







<li>For partial seizures in children, the recommended dose of Afinitor Disperz in 5 mg per square meter.</li>







</ul>
<p>If side effects become severe or your child's condition worsens, your doctor may change the dosage.</p>







<h3>What if I miss a dose?</h3>







<p>If you miss a dose of Afinitor, you can take it if it is within six hours or your normal scheduled dose. If more than six hours have passed, skip the dose and take the next dose at its normal time. Do not take two doses to make up for a missed dose. If you have questions about missing dose, talk with your doctor about what to do.</p>







<h3>Will I need to use this drug long term?</h3>







<p>Afinitor is meant to be used as a long-term treatment. If you and your doctor determine that Afinitor is safe and effective for you, you'll likely take it long term. If the side effects become severe or if your condition worsens, your doctor may have you stop taking Afinitor.</p>







<span class="anchor" id="cost"></span>
<!--[DLB]--><!-- Leaderboard BANNER advert -->

<div id="dlb2_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb2_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB2',
			"slotContainer":'dlb2_container'		});
	</script>
	</div>
	<span class='bt-uid-tg' data-uid='5b846471dd-160' style='display: none !important' ></span>

</div>






<!-- /header_ad code --><!--[END DLB]--><h2>Afinitor cost</h2>







<p>As with all medications, the cost of Afinitor can vary. To find current prices for Afinitor in your area, check out <a href="https://www.goodrx.com/afinitor" target="_blank" rel="noopener">GoodRx.com</a>:</p>







<div id="goodrx_fair-price_widget"></div>







<script>var _grxdn = "afinitor";(function(d,t){var g=d.createElement(t),s=d.getElementsByTagName(t)[0];g.src="//s3.amazonaws.com/assets.goodrx.com/static/widgets/fair.min.js";s.parentNode.insertBefore(g,s)}(document,"script"));</script><p>The cost you find on GoodRx.com is what you may pay without insurance. The actual price you'll pay depends on your insurance coverage and the pharmacy you use.</p>







<h3>Financial and insurance assistance</h3>







<p>Do you need financial support to pay for Afinitor? Or do you need help understanding your insurance coverage? Help is available.</p>







<p>Novartis, the manufacturer of Afinitor, offers a program called the Novartis Oncology Universal Co-Pay Program. For more information and to find out if you're eligible for support, call 877-577-7756. Or you can visit the <a href="http://www.copay.novartisoncology.com/" target="_blank" rel="noopener">program website</a>.</p>







<span class="anchor" id="uses"></span>
<h2>Afinitor uses</h2>







<p>The Food and Drug Administration (FDA) approves prescription drugs such as Afinitor to treat certain conditions. Afinitor is FDA-approved to treat a range of cancers, tumors, and seizures.</p>







<h3>Afinitor for breast cancer</h3>







<p>Afinitor may be prescribed for advanced hormone receptor-positive, HER2-negative breast cancer in women who have gone through menopause and who have already tried treatment with the drugs letrozole (Femara) or anastrozole (Arimidex). Afinitor for breast cancer is to be used with the anticancer drug exemestane (Aromasin).</p>







<p>In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical study</a>, women who took Afinitor and exemestane had a response rate of 12.6%. A response rate is the percentage of people whose cancer decreases or disappears with treatment. Response rate is another term for success rate. Women who took only exemestane had a 1.7% response rate.</p>







<p>The study also found that taking Afinitor and exemestane more than doubled the time people lived without their breast cancer getting worse. This was compared to people who took only exemestane.</p>







<h3>Afinitor for kidney cancer</h3>







<p>Afinitor may be prescribed for advanced renal cell carcinoma (kidney cancer) in adults who have already tried the anticancer drugs sunitinib (Sutent) or sorafenib (Nexavar).</p>







<p>In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical study</a>, people with kidney cancer who took Afinitor had a response rate of 2%. That's the percentage of people whose cancer decreased or disappeared with treatment. This was compared to a 0% response rate in people who received only supportive care (no cancer medication).</p>







<p>The study also found that taking Afinitor more than doubled the amount of time people lived without their kidney cancer getting worse. This was compared to people who received only supportive care (no cancer treatment).</p>







<h3>Afinitor for neuroendocrine tumors</h3>







<p>Afinitor may be prescribed for certain types of neuroendocrine tumors that have progressed in adults and that can't be treated by surgery.</p>







<p>Neuroendocrine tumors can be cancerous or benign (not cancerous). They may release hormones into your blood that affect a number of your body's functions. Therefore, symptoms of these tumors can vary depending on where the tumor is located and what hormones are being released. Afinitor is specifically approved for neuroendocrine tumors in the pancreas, lung, or stomach and gut.</p>







<p>In two <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a> of people with neuroendocrine tumors, taking Afinitor more than doubled the amount of time people lived without their tumors getting worse. This was compared to people who received only supportive care (no cancer medication).</p>







<p>People with neuroendocrine tumors in the lung or stomach and gut had a response rate of 2%. That's the percentage of people whose cancer decreased or disappeared with treatment. This was compared to people who received only supportive care, who had a response rate of 1%.</p>







<p>Afinitor isn't FDA-approved to treat neuroendocrine tumors called functioning carcinoid tumors. This type of tumor actively makes hormones.</p>







<h3>Afinitor for benign kidney tumor caused by TS</h3>







<p>Afinitor may be prescribed to treat renal angiomyolipoma in adults with the genetic disorder tuberous sclerosis (TS). Renal angiomyolipoma is a type of benign (not cancerous) kidney tumor.</p>







<p>In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical study</a> of adults with kidney tumors, 41.8% of people had the size of their tumors reduced by at least 50%. This was compared to a 0% response rate in people who received only supportive care (no cancer medication).</p>







<h3>Afinitor and Afinitor Disperz for brain tumor caused by TS</h3>







<p>Both Afinitor and Afinitor Disperz are approved to treat subependymal giant cell astrocytoma (SEGA), a benign (not cancerous) brain tumor. They're approved for this use in:</p>







<ul>
<li>adults with the genetic disorder tuberous sclerosis (TS)</li>







<li>children ages 1 year and older with TS</li>







</ul>
<p>In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical study</a> in adults with SEGA, 35% of people who took Afinitor had the size of their tumor reduced by at least 50%. In comparison, there was a 0% response rate in people who received only supportive care (no cancer medication).</p>







<p>In another <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">study</a>, at six months, 32% of people who took Afinitor had the size of their tumor reduced by at least 50%.</p>







<h3>Afinitor Disperz for seizures caused by TS</h3>







<p>Afinitor Disperz is approved for use with antiseizure drugs to treat partial seizures (also called focal onset seizures) in:</p>







<ul>
<li>adults with the genetic disorder tuberous sclerosis (TS)</li>







<li>children ages 2 years and older with TS</li>







</ul>
<p>In a <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical study</a> of people with tuberous sclerosis (TS) and partial seizures, Afinitor Disperz was taken along with antiseizure drugs. This drug combination reduced the number of seizures that people had by at least 50% for 28.2% to 40% of the people. Half of the people who took Afinitor Disperz had their number of seizures reduced by at least 29.3% to 39.6%.</p>







<h3>Afinitor and children</h3>







<p>Afinitor and Afinitor Disperz are approved to treat subependymal giant cell astrocytoma (SEGA), a benign (not cancerous) brain tumor in children ages 1 year and older who have tuberous sclerosis. Tuberous sclerosis is a genetic disorder.</p>







<p>Afinitor Disperz is also approved for use with antiseizure drugs to treat partial seizures (also called focal onset seizures) in children ages 2 years and older who have tuberous sclerosis.</p>







<span class="anchor" id="use-with-other-drugs"></span>
<h2>Afinitor use with other drugs</h2>







<p>Afinitor can be used alone or with certain other drugs.</p>







<h3>Afinitor with other cancer drugs</h3>







<p>For most cancers, Afinitor is typically used by itself. But for advanced hormone receptor-positive, HER2-negative breast cancer, Afinitor is prescribed with the anticancer drug exemestane (Aromasin). Both Afinitor and Aromasin have been approved for this use by the Food and Drug Administration (FDA).</p>







<p>Some drugs may be used off-label for other conditions. Off-label use is when a drug that's approved to treat one condition is used to treat a different condition.</p>







<p>Examples of other cancer drugs that are used off-label with Afinitor include:</p>







<ul>
<li>fulvestrant (Faslodex) to treat breast cancer</li>







<li>tamoxifen (Soltamox) to treat breast cancer</li>







<li>levatinib (Lenvima) to treat kidney cancer</li>







</ul>
<p>Combining drugs, and adding more drugs to your treatment plan, can increase the number and severity of side effects you have.</p>







<p>For example, kidney failure is a possible serious side effect of both Afinitor and levatinib. Both of these drugs also have warnings for people undergoing surgery because the drugs can delay surgery healing time. Using Afinitor and levatinib together is likely to increase your risk for kidney failure or trouble healing after surgery.</p>







<p>If you're concerned about how certain drug combinations might affect you, talk with your doctor.</p>







<h3>Afinitor with other antiseizure medications</h3>







<p>Afinitor Disperz is approved to be used along with antiseizure medications to treat partial seizures (also called focal onset seizures) associated with the genetic disorder tuberous sclerosis (TS).</p>







<p>Examples of antiseizure drugs that may be used with Afinitor include:</p>







<ul>
<li>levetiracetam (Keppra)</li>







<li>lamotrigine (Lamictal)</li>







<li>topiramate (Topamax)</li>







<li>valproic acid (Depakote)</li>







<li>carbamazepine (Tegretol)</li>







<li>phenytoin (Dilantin)</li>







</ul>
<p>Using Afinitor Disperz with certain antiseizure drugs, such as phenytoin, can decrease how well Afinitor Disperz works. The antiseizure drugs can make Afinitor Disperz break down more than usual in your body. This lessens the amount of Afinitor Disperz in your system.</p>







<p>If you're taking an antiseizure drug, tell your doctor. They may need to increase your Afinitor dose or recommend other treatment options.</p>







<span class="anchor" id="afinitor-and-alcohol"></span>
<!--[MMR]--><!--[END MMR]--><h2>Afinitor and alcohol</h2>







<p>There are no known interactions between Afinitor and alcohol. However, alcohol may interact with certain other chemotherapy medications.</p>







<p>Talk with your doctor about the risks of drinking alcohol with Afinitor.</p>







<span class="anchor" id="interactions"></span>
<h2>Afinitor interactions</h2>







<p>Afinitor can interact with several other medications. It can also interact with certain supplements as well as certain foods.</p>







<div id="middle-of-article"></div>
<p>Different interactions can cause different effects. For instance, some can interfere with how well a drug works, while others can increase the risk of side effects.</p>







<h3>Afinitor and other medications</h3>







<p>Below are lists of medications that can interact with Afinitor. These lists do not contain all drugs that may interact with Afinitor.</p>







<p>Before taking Afinitor, be sure to tell your doctor and pharmacist about all prescription, over-the-counter, and other drugs you take. Also tell them about any <a href="/articles/195878.php" title="Vitamins: What are they and what do they do?" class="keywords">vitamins</a>, herbs, and supplements you use. Sharing this information can help you avoid potential drug interactions.</p>







<p>If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.</p>







<p><strong>Drugs that increase or decrease how well Afinitor works</strong></p>







<p>Some medications interact with how Afinitor is broken down within your body. This can increase or decrease the level of Afinitor, affecting how well it works. If you take any of these medications, tell your doctor. They may need to change your dosage.</p>







<p>Examples of these drugs include:</p>







<ul>
<li>rifampin (Rifadin, Rimactane)</li>







<li>phenytoin (Dilantin)</li>







<li>phenobarbital</li>







<li>ritonavir (Norvir)</li>







<li>amiodarone (Nexterone, Pacerone)</li>







<li>ketoconazole (Nizoral, Extina, Xolegel)</li>







<li>verapamil (Calan, Isoptin)</li>







</ul>
<p><strong>ACE inhibitors</strong></p>







<p>Angiotensin-converting enzyme (ACE) inhibitors are <a href="/articles/270644.php" title="What is a normal blood pressure?" class="keywords">blood pressure</a> medications. Their side effects include angioedema (a type of swelling caused by an allergic reaction). Angioedema is also a possible side effect of taking Afinitor. Taking an ACE inhibitor with Afinitor may increase your risk of developing angioedema.</p>







<p>Symptoms of angioedema can include:</p>







<ul>
<li>swelling under your skin, typically in your eyelids, lips, hands, or feet</li>







<li>swelling in your throat</li>







<li>skin redness</li>







<li>large, thick bumps on your skin</li>







</ul>
<p>Angioedema may be severe, especially if swelling occurs in your throat. If you have any symptoms of angioedema, call your doctor right away. Call 911 if your symptoms feel life-threatening or if you think you're having a medical emergency.</p>







<p>Examples of ACE inhibitor drugs include:</p>







<ul>
<li>benazepril (Lotensin)</li>







<li>enalapril (Vasotec)</li>







<li>lisinopril (Prinivil, Zestril)</li>







<li>perindopril (Aceon)</li>







<li>quinapril (Accupril)</li>







<li>ramipril (Altace)</li>







<li>trandolapril (Mavik)</li>







</ul>
<p>If you develop angioedema, your doctor will probably have you stop taking both Afinitor and any ACE inhibitors.</p>







<h3>Afinitor and vaccinations</h3>







<p>Live vaccines haven't been studied in people being treated with Afinitor. Due to the increased risk of infection, avoid getting live vaccines while taking Afinitor. Also avoid close contact with people who recently received a live vaccine.</p>







<p>If you have questions about Afinitor and vaccinations, talk with your doctor.</p>







<h3>Afinitor and herbs and supplements</h3>







<p>Taking St. John's wort with Afinitor may make Afinitor work less well. If you take the supplement, talk with your doctor. They may want you to stop taking the supplement and will recommend another treatment option.</p>







<h3>Afinitor and foods</h3>







<p>Avoid eating grapefruit or drinking grapefruit juice while taking Afinitor. The fruit or juice can increase the amount of the drug in your body to dangerous levels. Talk with your doctor if you have any concerns.</p>







<span class="anchor" id="alternatives"></span>
<!--[DLB]--><div id="hl-incontent-video-ad"></div>
<div id="div-gpt-ad-out-of-page"></div>
<script type="text/javascript">
	googleAdSlotInfo.push({
		"slotName":'out-of-page',
		"slotContainer":'div-gpt-ad-out-of-page'	});
</script><!--[END DLB]--><h2>Alternatives to Afinitor</h2>







<p>Other drugs are available that can treat your condition. Some may be better suited for you than others. If you're interested in finding an alternative to Afinitor, talk with your doctor. They can tell you about other medications that may work well for you.</p>







<h3>Alternatives for breast cancer</h3>







<p>Other drugs besides Afinitor that may be used to treat the same type of breast cancer in women who have gone through menopause include:</p>







<ul>
<li>abemaciclib (Verzenio)</li>







<li>fulvestrant (Faslodex)</li>







<li>palbociclib (Ibrance)</li>







</ul>
<h3>Alternatives for kidney cancer</h3>







<p>Other drugs besides Afinitor that may be used to treat advanced renal cell carcinoma (kidney cancer) include:</p>







<ul>
<li>axitinib (Inlyta)</li>







<li>temsirolimus (Torisel)</li>







</ul>
<h3>Alternatives for neuroendocrine tumors of the pancreas, lung, or stomach/gut</h3>







<p>Other drugs besides Afinitor that may be used to treat neuroendocrine tumors include:</p>







<ul>
<li>lutetium Lu 177 (Lutathera)</li>







<li>sunitinib (Sutent)</li>







<li>streptozocin (Zanosar)</li>







</ul>
<h3>Alternatives for kidney tumors</h3>







<p>The Food and Drug Administration (FDA) hasn't approved other medications besides Afinitor to treat renal angiomyolipoma in people with tuberous sclerosis. Renal angiomyolipomas are benign (not cancerous) kidney tumors.</p>







<p>Sirolimus may be used off-label to treat benign (not cancerous) kidney tumors in people with tuberous sclerosis. Sirolimus is in the same class of drugs as Afinitor. Sirolimus has been <a href="https://doi.org/10.1371/journal.pone.0023379" target="_blank" rel="noopener">studied</a> in people with kidney tumors and tuberous sclerosis. However, the studies were small in size, and more studies are needed confirm how well the drug works.</p>







<h3>Alternatives for brain tumors</h3>







<p>The FDA hasn't approved other medications besides Afinitor and Afinitor Disperz to treat subependymal giant cell astrocytoma (SEGA). This is a benign (not cancerous) brain tumor in people with tuberous sclerosis.</p>







<h3>Alternatives for seizures</h3>







<p>The FDA hasn't approved other medications besides Afinitor Disperz to treat partial seizures (also called focal onset seizures) related to tuberous sclerosis in adults and children ages 2 years and older.</p>







<span class="anchor" id="afinitor-vs-ibrance"></span>
<h2>Afinitor vs. Ibrance</h2>







<p>You may wonder how Afinitor compares to other medications that are prescribed for similar uses. Here we look at how Afinitor and Ibrance are alike and different.</p>







<h3>Ingredients</h3>







<p>Afinitor contains the drug everolimus. It's a type of drug called a mammalian target of rapamycin (mTOR) inhibitor.</p>







<p>Ibrance contains the drug palbociclib. It's a type of drug called a cyclin-dependent kinase (CDK) 4 and 6 inhibitor.</p>







<p>Both Afinitor and Ibrance are targeted therapies, which work by "targeting" and attacking certain parts of cancer cells. However, the two drugs affect different enzymes (proteins that aid chemical changes in your body). Afinitor targets mTOR enzymes, while Ibrance targets CDK 4 and 6 enzymes. By blocking these enzymes, the two drugs prevent cancer cells from growing and spreading.</p>







<h3>Uses</h3>







<p>Afinitor and Ibrance are both similar and different in how they treat cancer, tumors, and seizures.</p>







<p><strong>Breast cancer</strong></p>







<p>The Food and Drug Administration (FDA) has approved both Afinitor and Ibrance to treat advanced hormone receptor-positive, HER2-negative breast cancer in women. However, the two drugs differ in some ways regarding their use in treating breast cancer.</p>







<p>Afinitor is approved for use with the anticancer drug exemestane (Aromasin) in women after menopause. The women must have already tried letrozole (Femara) or anastrozole (Arimidex), both anticancer drugs.</p>







<p>Ibrance is also approved to treat metastatic (advanced) breast cancer. This is breast cancer that has spread to other parts of the body. Ibrance is to be used with fulvestrant (Faslodex) in women whose cancer got worse after they tried endocrine (hormone) therapies including:</p>







<ul>
<li>letrozole (Femara)</li>







<li>anastrozole (Arimidex)</li>







<li>exemestane (Aromasin)</li>







</ul>
<p>Ibrance is also approved as the starting therapy for advanced or metastatic breast cancer in either women who have gone through menopause or men. Ibrance is to be used with an aromatase inhibitor (AI). AIs are a type of hormone therapy that blocks the production of <a href="/articles/277177.php" title="Everything you need to know about estrogen" class="keywords">estrogen</a>.</p>







<p><strong>Other cancers and tumors</strong></p>







<p>While Ibrance is only approved to treat breast cancer, Afinitor is approved to treat other cancers and tumors including:</p>







<ul>
<li>advanced renal cell carcinoma (kidney cancer) in adults who have already tried the anticancer drugs sunitinib (Sutent) or sorafenib (Nexavar)</li>







<li>neuroendocrine tumors in the pancreas, lung, or stomach/gut in adults that can't be treated with surgery</li>







<li>renal angiomyolipoma, a type of benign (not cancerous) kidney tumor in adults with the genetic disorder tuberous sclerosis</li>







<li>subependymal giant cell astrocytoma (SEGA), a type of benign (not cancerous) brain tumor in adults or children ages 1 year and older with tuberous sclerosis (Afinitor Disperz is also approved to treat these brain tumors.)</li>







</ul>
<p><strong>Partial seizures</strong></p>







<p>Afinitor Disperz is approved for use with antiseizure drugs to treat partial seizures (also called focal onset seizures) in:</p>







<ul>
<li>adults and children ages 2 years and older with tuberous sclerosis</li>







</ul>
<h3>Drug forms and administration</h3>







<p>Afinitor is available in two forms:</p>







<ul>
<li>
<strong>Afinitor</strong> comes as a tablet that you swallow. Be sure to take Afinitor tablets whole. Don't chew, split, or crush them. The tablets come in four strengths:</li>







<ul>
<li>2.5 mg</li>







<li>5 mg</li>







<li>7.5 mg</li>







<li>10 mg</li>







</ul>
<li>
<strong>Afinitor Disperz</strong> comes as a tablet that you must prepare as an oral suspension. This means you'll dissolve it in a liquid, which you then swallow. The tablets come in three strengths:</li>







<ul>
<li>2 mg</li>







<li>3 mg</li>







<li>5 mg</li>







</ul>
</ul>
<p>Ibrance comes as a capsule that you swallow. The drug is available in three strengths:</p>







<ul>
<li>75 mg</li>







<li>100 mg</li>







<li>125 mg</li>







</ul>
<h3>Side effects and risks</h3>







<p>Afinitor and Ibrance can cause similar side effects. Below are examples of these side effects.</p>







<p><strong>More common side effects</strong></p>







<p>These lists contain examples of more common side effects that can occur with Afinitor, with Ibrance, or with both drugs (when taken individually).</p>







<ul>
<li>
<strong>Can occur with Afinitor</strong>:</li>







<ul>
<li>weight loss</li>







<li>cough</li>







<li>swelling of your hands, arms, feet, ankles, or legs</li>







<li>abdomen (belly) pain</li>







</ul>
<li>
<strong>Can occur with Ibrance</strong>:</li>







<ul>
<li>hair loss</li>







<li>nose bleeds</li>







<li>altered taste</li>







</ul>
<li>
<strong>Can occur with both Afinitor and Ibrance</strong>:</li>







<ul>
<li>diarrhea</li>







<li>nausea</li>







<li>vomiting</li>







<li>stomatitis (sores or swelling in your mouth)</li>







<li>increased risk of infection</li>







<li>rash</li>







<li>weakness or lack of energy</li>







<li>headache</li>







<li>fatigue</li>







<li>loss of appetite</li>







<li>fever</li>







</ul>
</ul>
<p><strong>Serious side effects</strong></p>







<p>These lists contain examples of serious side effects that can occur with Afinitor, with Ibrance, or with both drugs (when taken individually).</p>







<ul>
<li>
<strong>Can occur with Afinitor</strong>:</li>







<ul>
<li>pneumonitis (swelling in the lungs)</li>







<li>angioedema (swelling under your skin, typically in your eyelids, lips, hands, or feet)</li>







<li>kidney failure</li>







</ul>
<li>
<strong>Can occur with Ibrance</strong>:</li>







<ul>
<li>few unique serious side effects</li>







</ul>
<li>
<strong>Can occur with both Afinitor and Ibrance</strong>:</li>







<ul>
<li>severe allergic reactions</li>







<li>myelosuppression (when bone marrow makes fewer blood cells)</li>







</ul>
</ul>
<h3>Effectiveness</h3>







<p>These drugs haven't been directly compared in head-to-head clinical studies. But researchers have found both <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">Afinitor</a> and <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s008lbl.pdf" target="_blank" rel="noopener">Ibrance</a> to be effective in treating advanced hormone receptor-positive, HER2-negative breast cancer in women who have:</p>







<ul>
<li>gone through menopause</li>







<li>already tried treatment with the drugs letrozole (Femara) or anastrozole (Arimidex)</li>







</ul>
<h3>Costs</h3>







<p>Afinitor and Ibrance are both brand-name drugs. They don't currently have generic forms. Brand-name medications usually cost more than generics.</p>







<p>According to estimates on <a href="https://www.goodrx.com/" target="_blank" rel="noopener">GoodRx.com</a>, Afinitor is more expensive than Ibrance. The actual price you'll pay for either drug will depend on your insurance plan, your location, and the pharmacy you use.</p>







<span class="anchor" id="how-to-take"></span>
<!--[MMR]--><!--[END MMR]--><h2>How to take Afinitor</h2>







<p>Take Afinitor as your doctor or healthcare provider instructs.</p>







<h3>Taking Afinitor</h3>







<p>Swallow Afinitor tablets whole. Don't chew, split, or crush them.</p>







<h3>Taking Afinitor Disperz</h3>







<p>For a helpful video on how to take Afinitor Disperz, visit the drug's <a href="https://www.us.afinitor.com/tsc-seizures/about-treatment/how-to-take/" target="_blank" rel="noopener">website</a>.</p>







<p>You must prepare Afinitor Disperz tablets as an oral suspension. This means you'll dissolve them in water, which you will then swallow.</p>







<p><strong>Preparing the suspension in a syringe</strong></p>







<p>If you have trouble drinking from a glass, you may want to use an oral syringe to take Afinitor.</p>







<p><em><strong>Preparing the suspension</strong></em></p>







<p>To prepare the suspension in a syringe, follow these steps:</p>







<div id="threequarter-of-article"></div>
<ol>
<li>Wash and dry your hands.</li>







<li>Put on disposable gloves. Avoid touching the medication if you're giving it to someone else.</li>







<li>Take the plunger out of a 10-mL oral syringe.</li>







<li>Place a tablet or tablets of the prescribed dose into the barrel of the syringe. Don't break or crush the tablets. You'll need another syringe for doses higher than 10 mg.</li>







<li>Put the plunger back in the barrel of the syringe and push until it touches the tablets.</li>







<li>Add water to a drinking glass.</li>







<li>Put the syringe tip in the glass. Pull back the plunger until there's about 5 mL of water in the syringe.</li>







<li>Turn the syringe so the tip is pointing up. Pull the plunger to add 4 mL of air into the syringe.</li>







<li>Empty the glass and place the syringe in it, tip up.</li>







<li>Wait three minutes until the tablets dissolve.</li>







</ol>
<p><em><strong>Taking the dose</strong></em></p>







<p>Now that you've prepared the suspension, you're ready to take the dose. Follow these steps:</p>







<ol>
<li>Gently turn the syringe end to end five times.</li>







<li>Hold the syringe tip up and press the plunger to remove extra air.</li>







<li>Place the syringe tip in your mouth and press the plunger. Be sure to take the dose within 60 minutes. If you don't, dispose of the suspension.</li>







<li>Draw up another 5 mL of water and 4 mL of air into the same syringe.</li>







<li>Swirl as before to get the remaining drugs into the suspension. Then take the rest of the dose right away.</li>







<li>Wash and dry your hands.</li>







</ol>
<p><strong>Preparing the suspension in a small drinking glass</strong></p>







<p>You don't have to use an oral syringe to take Afinitor. You can also prepare the suspension in a small glass. Follow these steps:</p>







<ol>
<li>Wash and dry your hands.</li>







<li>Put on disposable gloves and avoid touching the medication if you're giving it to someone else.</li>







<li>Place the prescribed dose into a small drinking glass with about 25 mL of water. Don't break or crush the tablets. If your dose is higher than 10 mg, you'll need to split the dose. That means repeating these steps to take the rest of the dose. There should be a maximum dose of 10 mg per glass.</li>







<li>Wait three minutes until the tablets dissolve.</li>







<li>Stir the suspension gently with a spoon.</li>







<li>Drink the suspension. Be sure to do so within 60 minutes of preparing it.</li>







<li>Add another 25 mL of water to the glass. Stir with the same spoon to get the remaining drugs into the suspension. Then drink the rest of the suspension right away.</li>







<li>Wash and dry your hands.</li>







</ol>
<h3>Timing</h3>







<p>Take Afinitor once a day at the same time each day.</p>







<h3>Duration of treatment</h3>







<p>People may take Afinitor for different lengths of time. This is based on how they well their body tolerates the drug. It's also based on whether the disease progresses, and when that progression occurs.</p>







<h3>Taking Afinitor with food</h3>







<p>You can take Afinitor with or without food.</p>







<h3>Can Afinitor be crushed, split, or chewed?</h3>







<p>No. You shouldn't crush, split, or chew Afinitor or Afinitor Disperz tablets.</p>







<span class="anchor" id="how-it-works"></span>
<h2>How Afinitor works</h2>







<p>Afinitor is used to treat many types of cancer and tumors. It's also used to treat partial seizures (also called focal onset seizures) for people with the genetic disorder tuberous sclerosis.</p>







<p>Afinitor is a type of drug called a mammalian target of rapamycin (mTOR) inhibitor. An mTOR is a protein (enzyme) that helps cells grow and divide. mTOR inhibitors work by inhibiting (stopping) cancer cells from getting bigger and spreading.</p>







<p>Afinitor also helps treat tuberous sclerosis-related seizures, but how it does this isn't completely understood. Tuberous sclerosis seizures are thought to be caused in part by inflammation from tumors. One theory is that blocking mTOR reduces inflammation between nerve cells in the brain, which could help reduce seizures.</p>







<h3>How long does it take to work?</h3>







<p>The effectiveness of cancer drugs is usually measured by a response rate. Response rates can be monitored by different types of tests. You and your doctor will create a plan to monitor your treatment and response. If the drug works, it may take a few weeks or longer to notice a response to the drug.</p>







<span class="anchor" id="pregnancy"></span>
<h2>Afinitor and pregnancy</h2>







<p>You shouldn't take Afinitor if you're planning on becoming pregnant or are currently pregnant. In <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">animal studies</a>, Afinitor was harmful to the fetus when the mother was given the drug.</p>







<p>Women should use <a href="/articles/162762.php" title="What types of birth control are there?" class="keywords">contraception</a> (birth control) during Afinitor treatment and for eight weeks after their last dose. Men should also use birth control during treatment and for four weeks after their last dose.</p>







<span class="anchor" id="breastfeeding"></span>
<!--[DLB]--><!-- Leaderboard BANNER advert -->

<div id="dlb3_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb3_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB3',
			"slotContainer":'dlb3_container'		});
	</script>
	</div>
	

</div>






<!-- /header_ad code --><!--[END DLB]--><h2>Afinitor and breastfeeding</h2>







<p>It isn't known if Afinitor passes into human breast milk. <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">Animal studies</a> have shown that Afinitor passes into breast milk at a high level. However, animal studies don't always predict what will occur in humans.</p>







<p>Because the effects are not known, it is recommended that women not breastfeed during treatment with Afinitor and for two weeks after their last dose.</p>







<p>If you have any concerns about breastfeeding and taking Afinitor, talk with your doctor.</p>







<span class="anchor" id="faqs"></span>
<!--[MMR]--><!--[END MMR]--><h2>Common questions about Afinitor</h2>







<p>Here are answers to some frequently asked questions about Afinitor.</p>







<h3>Is Afinitor chemotherapy?</h3>







<p>No, Afinitor isn't a type of chemotherapy. Afinitor is a type of drug called a mammalian target of rapamycin (mTOR) inhibitor, which is considered a targeted therapy. Targeted therapy works by "targeting" and attacking cancer cells.</p>







<p>Chemotherapy medications are different than targeted therapies. Chemotherapy drugs act on all cells in the body that are growing quickly, not just cancer cells. Chemotherapy medications usually kill the growing cells and affect more cells in the body than targeted therapy does.</p>







<h3>What can I do to prevent mouth sores from Afinitor?</h3>







<p>To help keep your mouth healthy and free from sores, practice good dental hygiene. Brush your teeth twice a day and floss once a day. Also, eat a healthy diet and look for any changes in your mouth. If you notice any mouth problems, tell your doctor.</p>







<p>You can also try using an alcohol-free mouthwash while being treated with Afinitor. This may help reduce your risk for mouth sores.</p>







<p>According to a <a href="https://pdfs.semanticscholar.org/ddcd/e261988a912ded0415cc5c3087dd5cd3ccfc.pdf" target="_blank" rel="noopener">2017 review</a>, researchers are looking at several ways to help prevent mouth sores in people using Afinitor or other drugs from the same class. Studies haven't yet proven that these methods are effective, but possible options include:</p>







<ul>
<li>brushing and gargling with salt water</li>







<li>rinsing with and swallowing a glutamine solution (available in drug stores as a powder or a premade solution called Healios)</li>







<li>using a hydrocortisone mouthwash or a prednisolone rinse (available by prescription only)</li>







<li>using an alcohol-free mouthwash that contains dexamethasone (available by prescription only)</li>







<li>taking prednisone (available by prescription only)</li>







</ul>
<p>If you want to help prevent mouth sores, talk with your doctor. They can suggest the best options for you.</p>







<h3>Can I use this drug if I haven't reached menopause?</h3>







<p>Maybe. The Food and Drug Administration (FDA) has approved Afinitor to treat advanced hormone receptor-positive, HER2-negative breast cancer in women who have gone through menopause.</p>







<p>In theory, Afinitor could be used to treat this cancer in women who haven't yet gone through menopause. However, there's no evidence available yet that the drug would work.</p>







<p>If you haven't yet reached menopause and want to learn more about Afinitor, talk with your doctor.</p>







<h3>Is Afinitor the same as Zortress?</h3>







<p>Afinitor and Zortress are both prescription medications that contain the drug everolimus. However, they're used for different purposes and prescribed at different doses.</p>







<p>Afinitor is approved to treat many types of cancers and tumors, and is prescribed at higher doses. Zortress is approved at much lower doses to help prevent organ rejection in people who have had a kidney or liver transplant.</p>







<h3>Is Afinitor used to treat carcinoid tumors?</h3>







<p>Yes and no. Afinitor is approved to treat nonfunctional types of carcinoid tumors of the pancreas, lungs, and stomach or gut. Nonfunctional tumors don't produce hormones. (Another name for carcinoid tumors is neuroendocrine tumors. These are tumors that grow in and around nerve cells and cells that make hormones.)</p>







<p>Afinitor isn't approved to treat functional carcinoid tumors. These are tumors that actively release hormones.</p>







<span class="anchor" id="warnings"></span>
<h2>Afinitor warnings</h2>







<p>Before taking Afinitor, talk with your doctor about your health history. In some cases, Afinitor may not be right for you based on your health history. Talk with your doctor if any of the following applies to you:</p>







<ul>
<li>
<strong>Surgical healing</strong>. Afinitor may delay your recovery time after surgery. It may also increase your risk for wound-related complications, including reopening and infections of the wound. Talk with your doctor if you've recently had surgery or are planning to have it soon.</li>







<li>
<strong>Older age</strong>. In the breast cancer <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical study</a>, people ages 65 and older had a higher rate of stopping Afinitor and death. This was compared to people in younger age groups. If you're age 65 or older, your doctor should carefully monitor your Afinitor dose. Then they should adjust it to help you avoid side effects.</li>







<li>
<strong>Metabolic disorders</strong>. Afinitor has been reported in <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a> to cause high levels of blood sugar, cholesterol, and triglycerides. If you have diabetes or another metabolic disorder, your doctor will carefully monitor your levels before and during your Afinitor treatment.</li>







<li>
<strong>Liver problems</strong>. According to <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">clinical studies</a>, if you've had <a href="/articles/306288.php" title="Everything you need to know about hepatitis B" class="keywords">hepatitis B</a>, taking Afinitor may cause the infection to return. Also, your doctor may need to adjust your dosage of Afinitor if you have liver problems. Before you take Afinitor, tell your doctor if you have liver problems or have ever had hepatitis B.</li>







</ul>
<span class="anchor" id="overdose"></span>
<h2>Afinitor overdose</h2>







<p>Using more than the recommended dose of Afinitor can lead to serious and life-threatening side effects.</p>







<h3>Overdose symptoms</h3>







<p>Symptoms of taking too much Afinitor can include:</p>







<ul>
<li>stomatitis (sores or swelling in your mouth)</li>







<li>infections</li>







<li>pneumonitis (swelling in the lungs that's not caused by an infection)</li>







<li>kidney failure</li>







<li>myelosuppression (when bone marrow makes fewer blood cells)</li>







</ul>
<h3>What to do if you take too much</h3>







<p>If you think you've taken too much of Afinitor, call your doctor. You can also call the American Association of Poison Control Centers at 800-222-1222 or use their <a href="https://www.poisonhelp.org/help" target="_blank" rel="noopener">online tool</a>. <strong>But if your symptoms are severe, call 911 or go to the nearest emergency room right away</strong>.</p>







<span class="anchor" id="expiration"></span>
<h2>Afinitor expiration, storage, and disposal</h2>







<p>When you get Afinitor from the pharmacy, the pharmacist will add an expiration date to the label on the bottle. This date is typically one year from the date they dispensed the medication.</p>







<p>The expiration date helps guarantee the effectiveness of the medication during this time. The <a href="https://www.fda.gov/drugs/special-features/dont-be-tempted-use-expired-medicines" target="_blank" rel="noopener">current stance</a> of the Food and Drug Administration (FDA) is to avoid using expired medications. If you have unused medication that has gone past the expiration date, talk to your pharmacist about whether you might still be able to use it.</p>







<h3>Storage</h3>







<p>How long a medication remains good can depend on many factors, including how and where you store the medication.</p>







<p>Store Afinitor tablets at room temperature in their original container. Be sure to protect them from light and moisture.</p>







<h3>Disposal</h3>







<p>If you no longer need to take Afinitor and have leftover medication, it's important to dispose of it safely. This helps prevent others, including children and pets, from taking the drug by accident. It also helps keep the drug from harming the environment.</p>







<p>The <a href="https://www.fda.gov/consumers/consumer-updates/where-and-how-dispose-unused-medicines" target="_blank" rel="noopener">FDA website</a> provides several useful tips on medication disposal. You can also ask your pharmacist for information on how to dispose of your medication.</p>







<span class="anchor" id="for-professionals"></span>
<!--[DLB]--><!-- Leaderboard BANNER advert -->

<div id="dlb4_container" class="mnt css_c4zij" >


<!-- header_ad code -->
<div class="mnt_history" style="display:none;">

	<a href="/whitelist-mnt"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_history_leaderboard.png" alt="Thank you for supporting Medical News Today"/></a>


</div>
    <div id='dlb4_unit' adonis-marker>
	<script type='text/javascript'>
		googleAdSlotInfo.push({
			"slotName":'DLB4',
			"slotContainer":'dlb4_container'		});
	</script>
	</div>
	

</div>






<!-- /header_ad code --><!--[END DLB]--><!--[MMR]--><!--[END MMR]--><h2>Professional information for Afinitor</h2>







<p>The following information is provided for clinicians and other healthcare professionals.</p>







<h3>Indications</h3>







<p>Afinitor is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of:</p>







<ul>
<li>Advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women who have gone through menopause. Afinitor is approved to be used with exemestane after failed treatment with letrozole or anastrozole.</li>







<li>Progressive locally advanced or metastatic neuroendocrine tumors (NET) from the pancreas that are inoperable in adults.</li>







<li>Progressive locally advanced or metastatic NETs from the gastrointestinal tract or lungs that are well-differentiated, nonfunctional, and inoperable in adults.</li>







<li>Advanced renal cell carcinoma in adults who have failed treatment with sunitinib or sorafenib.</li>







<li>Tuberous sclerosis (TSC)-associated renal angiomyolipoma in adults who do not need immediate surgery.</li>







</ul>
<p>Afinitor is not approved for the treatment of functional carcinoid tumors.</p>







<p>Afinitor and Afinitor Disperz are approved for adult and pediatric patients ages 1 year and older with TSC-associated subependymal giant cell astrocytoma (SEGA) that requires treatment but cannot be curatively removed.</p>







<p>Afinitor Disperz is approved for the adjunctive treatment of TSC-associated partial seizures (focal onset seizures) in adult and pediatric patients ages 2 years and older.</p>







<h3>Mechanism of action</h3>







<p>Afinitor inhibits mTOR, a kinase enzyme. In cancer and tuberous sclerosis, the mTOR pathway is not properly regulated, leading to cancer or tumor growth. Afinitor blocks mTOR and interferes with various mechanisms including protein synthesis and cell growth.</p>







<p>The mechanism of action between mTOR inhibition and TSC-related seizures is not well understood. Other seizure disorders have been connected to mTOR dysregulation. Thus, inhibition of mTOR may be a novel mechanism for the management of seizures.</p>







<h3>Pharmacokinetics and metabolism</h3>







<p>Peak concentration occurs one to two hours after administration. Once-daily dosing of Afinitor reaches steady-state within two weeks.</p>







<p>Afinitor is a CYP3A4 substrate and is metabolized in the liver. It is eliminated primarily through the feces. The average half-life of Afinitor is about 30 hours.</p>







<h3>Contraindications</h3>







<p>Afinitor is contraindicated in people with have severe allergic reactions to everolimus or drugs within the same class.</p>







<h3>Storage</h3>







<p>Afinitor tablets should be stored at room temperature in their original container. They should be protected from light and moisture. Anticancer medications should be handled and discarded properly.</p>







<p><strong>Disclaimer</strong>: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up-to-date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or other healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.</p>
<div id="bottom-of-article"></div>
 	</div> 	</div> 
<style type="text/css">
		/*.mnt_dlb_foot_container { display:block; width: 728px; height: 90px; }*/
		/*@media (min-width: 990px) { .mnt_dlb_foot_container { display: none; } }
		@media (min-width:1148px) { .mnt_dlb_foot_container { display:block;} }*/
</style>
<!-- MNT_Adsense_Desktop_728x90 Footer -->
<ins class="adsbygoogle mnt_dlb_foot_container"
	 id="mnt_dlb_foot_container"
     style="display:inline-block;width:728px;height:90px"
     data-ad-client="ca-pub-4771166113579725"
     data-ad-slot="9436500920"></ins>


<script>


	fireOrSaveJsFunctions(1,function(){loadScript(
		"//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js",
		{},
		function(){}

	)});


</script>
<script>(adsbygoogle = window.adsbygoogle || []).push({});</script>



<p id='slidebox_trigger'></p>

	<div id="suggest_reading_outer_container" class="place full">

		<h2 class="suggested_reading internal_related">Related coverage</h2>
	<span></span>
		<!--<h2 class="suggested_reading">Suggested Reading</h2>-->
	
	<div itemscope itemtype="http://schema.org/WebPage"> <!-- suggested_reading_container_parent -->
	<div class="suggested_reading_container ">
				<div class='suggested_reading_inner column1'>
				<div class="suggested_item">
		<a href="/articles/323642.php" title="What to know about focal (partial) seizures" class="related_coverage_link" data-id="323642">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/323/323642/323642_1100.jpg" alt="" />
		</div>
				<span class="title">What to know about focal (partial) seizures</span>
		<span class="summary">Focal seizures, also called partial seizures, happen when a seizure affects only one part of the brain. Focal seizures differ from generalized seizures, which affect the whole brain. Focal seizures can be simple or complex. In this article, we discuss the types, symptoms, causes, and treatment of focal seizures.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column2'>
				<div class="suggested_item">
		<a href="/articles/325654.php" title="What is the link between age and breast cancer?" class="related_coverage_link" data-id="325654">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/325/325654/325654_1100.jpg" alt="" />
		</div>
				<span class="title">What is the link between age and breast cancer?</span>
		<span class="summary">A person's risk of breast cancer increases with age. Doctors most commonly diagnose the condition in females over the age of 50. However, there are many other factors that can affect the chances of developing breast cancer. Learn about these risk factors, as well as the benefits and risks of regular screening, here.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column3'>
				<div class="suggested_item">
		<a href="/articles/317978.php" title="Kidney cancer prognosis: What you need to know" class="related_coverage_link" data-id="317978">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/headlines/317/317978/urine-sample.jpg" alt="" />
		</div>
				<span class="title">Kidney cancer prognosis: What you need to know</span>
		<span class="summary">Kidney cancer is a common cancer. Sometimes, effective treatment is possible and there will be a remission. This depends on the stage, type, and other individual factors. Find out more.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column4'>
				<div class="suggested_item">
		<a href="/articles/320439.php" title="What to know about breast cancer and back pain" class="related_coverage_link" data-id="320439">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/320/320439/320439_1100.jpg" alt="" />
		</div>
				<span class="title">What to know about breast cancer and back pain</span>
		<span class="summary">Back pain can be a problem in the later stages of breast cancer but is unlikely to be an early sign of the disease. Find out more about why it happens and what to do.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
						<div class='suggested_reading_inner column5'>
				<div class="suggested_item">
		<a href="/articles/320588.php" title="What to know about complex partial seizures" class="related_coverage_link" data-id="320588">
				<div class="suggested_item_image">
			<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/320/320588/320588_1100.jpg" alt="" />
		</div>
				<span class="title">What to know about complex partial seizures</span>
		<span class="summary">A look at complex partial seizures, a form of seizure that occurs in just one part of the brain. Included is what to do if someone has a seizure.</span>
		
			<span class="more">Read now</span>
			</a>
	</div> 				</div>
				</div>
	</div>
	</div>
	

<div id="social_bottom"  >			
    <div id="share_social_bottom">    
        <div id="article_social_bottom_facebook" ></div>
        <div id="article_social_bottom_twitter" ></div>
        <div id="article_social_bottom_linkedin" ></div>

		    
    </div>
    <div class="toolbox">
		<div class="email">            <a rel="nofollow" title="email this article" href="#">
			<span class="toolbox_label">email</span></a>
            <span class="visuallyhidden">
            <a rel="nofollow" title="email this article" href="#">email</a>
            </span>
        </div>        
		        <div class="print">			            <a id="dc84668b5c36f152a88ae420d1abd57f" href="#" rel="nofollow" title="View print preview" target="_blank">
			<span class="toolbox_label">print</span></a>
        </div>        		
		<div class="share">            <a rel="nofollow" title="share this article" href="#">
			<span class="toolbox_label">share</span></a>
            <span class="visuallyhidden">
            <a rel="nofollow" title="share this article" href="#">share</a>
            </span>
        </div>

    </div>

</div><a id="rate-this-article"></a>	<div class="article_category_container">
					<div class="article_main_category_container"> 
				<span itemprop="genre" class="category_main">
				<a href="/categories/urology-nephrology" title="Urology / Nephrology News" class="current">Urology / Nephrology</a>
				</span>
			</div> 					<div class="article_sub_category_container">
				</div> 	</div> 	                    <div class="widget_citation_group" id="widget_citation">

                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading active">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#additional">
                                        Additional information</a>
                                </h4>
                            </div>
                            <div id="additional" class="panel-collapse collapse in">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="additional" >

		<p> Article last reviewed by Thu 23 May 2019.<br><br>Visit our <a href='/categories/urology-nephrology' title='Visit our Urology / Nephrology category page'>Urology / Nephrology</a> category page for the latest news on this subject, or <a href='/newsletter' title='Sign up to our newsletter'>sign up to our newsletter</a> to receive the latest updates on Urology / Nephrology.<br><br>All references are available in the <b>References</b> tab.		</p>
	</ul>
	                                </div>
                            </div>
                        </div>


                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#references">
                                        References</a>
                                </h4>
                            </div>
                            <div id="references" class="panel-collapse collapse">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="references" >
		<noscript> 
		This content requires JavaScript to be enabled.<br/><br/> 
		</noscript>
		<p>
		<p>Afinitor - everolimus tablet; Afinitor Disperz - everolimus tablet, for suspension. (2018). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2150f73a-179b-4afc-b8ce-67c85cc72f04</a></p>
<p>Aromasin - exemestane tablet. (2018). <a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf066b7a-032a-416c-8d40-15ba581423e3" target="_blank" rel="noopener">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf066b7a-032a-416c-8d40-15ba581423e3</a></p>
<p>Baselga J, et al. (2018). Everolimus in postmenopausal hormone-receptor–positive advanced breast cancer. <a href="https://www.nejm.org/doi/10.1056/NEJMoa1109653" target="_blank" rel="noopener">https://www.nejm.org/doi/10.1056/NEJMoa1109653</a></p>
<p>Chemotherapy for breast cancer. (2017). <a href="https://www.cancer.org/cancer/breast-cancer/treatment/chemotherapy-for-breast-cancer.html" target="_blank" rel="noopener">https://www.cancer.org/cancer/breast-cancer/treatment/chemotherapy-for-breast-cancer.html</a></p>
<p>Chemotherapy for kidney cancer. (2017). <a href="https://www.cancer.org/cancer/kidney-cancer/treating/chemotherapy.html" target="_blank" rel="noopener">https://www.cancer.org/cancer/kidney-cancer/treating/chemotherapy.html</a></p>
<p>Dabora SL, et al. (2011). Multicenter phase 2 trial of sirolimus for tuberous sclerosis: Kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023379" target="_blank" rel="noopener">https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023379</a></p>
<p>Don't be tempted to use expired medicines. (2016). <a href="https://www.fda.gov/drugs/resourcesforyou/specialfeatures/ucm481139.htm" target="_blank" rel="noopener">https://www.fda.gov/drugs/resourcesforyou/specialfeatures/ucm481139.htm</a></p>
<p>GoodRx. (n.d.). <a href="https://www.goodrx.com/" target="_blank" rel="noopener">https://www.goodrx.com/</a></p>
<p>Ibrance (palbociclib) capsules, for oral use. (2019). <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s008lbl.pdf" target="_blank" rel="noopener">https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207103s008lbl.pdf</a></p>
<p>Immunotherapy for kidney cancer. (2019). <a href="https://www.cancer.org/cancer/kidney-cancer/treating/immunotherapy.html" target="_blank" rel="noopener">https://www.cancer.org/cancer/kidney-cancer/treating/immunotherapy.html</a></p>
<p>Li M, et al. (2019). Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: A meta-analysis. <a href="https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1012-x" target="_blank" rel="noopener">https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1012-x</a></p>
<p>Ostendorf AP, et al. (2015). mTOR inhibition in epilepsy: rationale and clinical perspectives [Abstract]. <a href="https://link.springer.com/article/10.1007%2Fs40263-014-0223-x" target="_blank" rel="noopener">https://link.springer.com/article/10.1007%2Fs40263-014-0223-x</a></p>
<p>Sepsis: What are the signs and symptoms? (2018). <a href="https://www.cdc.gov/sepsis/signs-symptoms.html" target="_blank" rel="noopener">https://www.cdc.gov/sepsis/signs-symptoms.html</a></p>
<p>Shinohara E. (2018). All about carcinoid (neuroendocrine) tumors. <a href="https://www.oncolink.org/cancers/carcinoid-neuroendocrine-tumors/all-about-carcinoid-neuroendocrine-tumors" target="_blank" rel="noopener">https://www.oncolink.org/cancers/carcinoid-neuroendocrine-tumors/all-about-carcinoid-neuroendocrine-tumors</a></p>
<p>Staves KL, et al. (2017). Prevention and treatment options for mTOR inhibitor-associated stomatitis. <a href="https://www.mdedge.com/hematology-oncology/article/137232/patient-survivor-care/prevention-and-treatment-options-mtor" target="_blank" rel="noopener">https://www.mdedge.com/hematology-oncology/article/137232/patient-survivor-care/prevention-and-treatment-options-mtor</a></p>
<p>Targeted therapy for breast cancer. (2018). <a href="https://www.cancer.org/cancer/breast-cancer/treatment/targeted-therapy-for-breast-cancer.html" target="_blank" rel="noopener">https://www.cancer.org/cancer/breast-cancer/treatment/targeted-therapy-for-breast-cancer.html</a></p>
<p>Targeted therapies for kidney cancer. (2019). <a href="https://www.cancer.org/cancer/kidney-cancer/treating/targeted-therapy.html" target="_blank" rel="noopener">https://www.cancer.org/cancer/kidney-cancer/treating/targeted-therapy.html</a></p>
<p>Types of blood pressure medications. (2017). <a href="https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/types-of-blood-pressure-medications" target="_blank" rel="noopener">https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can-make-to-manage-high-blood-pressure/types-of-blood-pressure-medications</a></p>
<p>Wong, M. (2013). mTOR as a potential treatment target for epilepsy. <a href="https://www.futuremedicine.com/doi/10.2217/fnl.12.45" target="_blank" rel="noopener">https://www.futuremedicine.com/doi/10.2217/fnl.12.45</a></p>
<p>Zhang B, et al. (2015). Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex. <a href="https://www.sciencedirect.com/science/article/pii/S0969996115001722?via%3Dihub" target="_blank" rel="noopener">https://www.sciencedirect.com/science/article/pii/S0969996115001722?via%3Dihub</a></p>		</p>
	</ul>
	                                </div>
                            </div>
                        </div>


                        <div class="panel widget_citation_panel">
                            <div class="panel-heading widget_citation_heading">
                                <h4 class="panel-title">
                                    <a data-toggle="collapse" data-parent="#widget_citation" href="#citations">
                                        Citations</a>
                                </h4>
                            </div>
                            <div id="citations" class="panel-collapse collapse">
                                <div class="panel-body widget_citation_body">
                                    	<ul id="citations" >
		<p>Please use one of the following formats to cite this article in your essay, paper or report:</p><p><strong>MLA</strong><br />Nguyen, Victor. "Afinitor (everolimus)." <i>Medical News Today</i>. MediLexicon, Intl., 31 Aug. 2019. Web.<br>6 Sep. 2019. &lt;https://www.medicalnewstoday.com/articles/326055.php&gt;</p><hr size="1" /><p><strong>APA</strong><br />Nguyen, V. (2019, August 31). "Afinitor (everolimus)." <i>Medical News Today</i>. Retrieved from<br><a href='https://www.medicalnewstoday.com/articles/326055.php' itemprop='url'>https://www.medicalnewstoday.com/articles/326055.php</a>.</p><hr size="1" /><p>Please note: If no author information is provided, the source is cited instead.</p>	</ul>
	                                </div>
                            </div>
                        </div>

                    </div>


					
	<hr class="nonprint"/>
<div class="article_email">
	<div id="header_close_button" class="email_close"></div>
	<div class="emailform_container">

	</div>
</div></div>  
</article>

	<div class="col-xs-12 col-sm-12 col-md-4 col-lg-4 sidebar"> 
<!-- article_ad code -->
<!-- MREC ARTICLE advert -->
<div id="dmr1_container" class="mnt css_hs211">

<div class="mnt_history" style="display:none;">
	<a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_knowledge_center_001.png" alt="MNT Knowledge Center" /></a>
 	

</div>

		<div id='dmr1_unit' adonis-marker>
		<script type='text/javascript'>
			googleAdSlotInfo.push({
				"slotName":'DMR1',
				"slotContainer":'dmr1_container'			});
		</script>
		</div>
		<span class='bt-uid-tg' data-uid='5b84643d24-160' style='display: none !important'></span></div> <!-- /article_ad code -->
	<div id="sidebar_feature" class="full">
			<h2>Latest news</h2>
		<span></span>
	<ul class="sidebar_feature">
	<li>	<a href="/articles/326281.php" title="Curiosities of medical history: Trepanation">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326281/326281_1100.jpg" alt="Curiosities of medical history: Trepanation" class="original">
	<div class="headline">Curiosities of medical history: Trepanation</div> 
	<div class="excerpt">Trepanation is the historical practice of drilling holes into the skull. But why did our ancestors do it, and when did it start? We investigate.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326278.php" title="Scientists identify genetic components of left-handedness">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326278/326278_1100.jpg" alt="Scientists identify genetic components of left-handedness" class="original">
	<div class="headline">Scientists identify genetic components of left-handedness</div> 
	<div class="excerpt">In a genetic analysis of 400,000 people, scientists have, for the first time, identified four DNA regions associated with left-handedness.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326243.php" title="World first: Doctors use 'reprogrammed' stem cells to repair cornea">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326243/326243_1100.jpg" alt="World first: Doctors use 'reprogrammed' stem cells to repair cornea" class="original">
	<div class="headline">World first: Doctors use 'reprogrammed' stem cells to repair cornea</div> 
	<div class="excerpt">In a groundbreaking procedure, surgeons have successfully repaired a human cornea using 'reprogrammed' cells from the patient's skin. </div>
	</div>

	</a></li>
	<li>	<a href="/articles/326232.php" title="Inflammation in late teens linked to mortality risk decades later">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326232/326232_1100.jpg" alt="Inflammation in late teens linked to mortality risk decades later" class="original">
	<div class="headline">Inflammation in late teens linked to mortality risk decades later</div> 
	<div class="excerpt">Experts know little about how inflammation in early life affects health later on. A new study links teen inflammation to mortality risk 35 years later.</div>
	</div>

	</a></li>
	<li>	<a href="/articles/326271.php" title="Scientists identify a trigger for type 1 diabetes in mice">
	<div>

	<img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAQAAAADCAQAAAAe/WZNAAAADklEQVR42mNkgAJGDAYAAFEABCaLYqoAAAAASUVORK5CYII=" data-src="https://cdn-prod.medicalnewstoday.com/content/images/hero/326/326271/326271_1100.jpg" alt="Scientists identify a trigger for type 1 diabetes in mice" class="original">
	<div class="headline">Scientists identify a trigger for type 1 diabetes in mice</div> 
	<div class="excerpt">Scientists discover a previously unknown switch that causes immune cells to begin destroying insulin, resulting in the onset of type 1 diabetes. </div>
	</div>

	</a></li>
		</ul>
	</div>
		<!-- article_ad code -->
<!-- MREC ARTICLE advert -->
<div id="dmr2_container" class="mnt css_hs211">

<div class="mnt_history" style="display:none;">
	<a href="/knowledge-center"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/mnt_ads/mnt_knowledge_center_001.png" alt="MNT Knowledge Center" /></a>
 	

</div>

		<div id='dmr2_unit' adonis-marker>
		<script type='text/javascript'>
			googleAdSlotInfo.push({
				"slotName":'DMR2',
				"slotContainer":'dmr2_container'			});
		</script>
		</div>
		<span class='bt-uid-tg' data-uid='5b846454f2-160' style='display: none !important'></span></div> <!-- /article_ad code -->
	<div class="full popular_tabs_container"> 	<div class="full popular_tabs_parent"> 	<h2 class="popular_tabs_heading"><span>Popular in: </span>Urology / Nephrology</h2><span></span>
	<div id="popular_tabs">
	<div class="centered">
	
	<ul class="nav">
		</ul>
	
			<div class="list-wrap">
					<ul id="popular-read">
				<li class="knowledge">
	<a href="/articles/324102.php" title="Trece remedios caseros y naturales para los cálculos renales">
		<span class="headline">
	Trece remedios caseros y naturales para los cálculos renales	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/324443.php" title="What causes cloudy urine?">
		<span class="headline">
	What causes cloudy urine?	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/324795.php" title="What causes a constant urge to pee?">
		<span class="headline">
	What causes a constant urge to pee?	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/323105.php" title="What can make urination painful?">
		<span class="headline">
	What can make urination painful?	</span>
		</a></li>
		<li class="knowledge">
	<a href="/articles/323957.php" title="What is the normal pH range for urine?">
		<span class="headline">
	What is the normal pH range for urine?	</span>
		</a></li>
				<span></span> 			</ul>
					</div> <!-- /list_wrap -->
			</div> <!-- /the_tabs -->
	</div> <!-- /centered -->
	</div> 	</div> 	</div> <!-- /sidebar -->
</div> 
</div> 


	<img height="1" width="1" src="https://d.turn.com/r/dd/id/L21rdC84MTYvY2lkLzE3NDc2NjAwNjEvdC8y/kv/CampaignID=MedicalNewsToday,Content=kidneycancer">

<div id="message"><a href="#top" style="display: none;">Scroll to top</a></div>


<footer>

<div class="container">

	<div class="row"> 	
		<div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 footer"> 		
			<div id="footer_logo">
				<a href="/"  title="Medical News Today : Home">
					<img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://cdn-prod.medicalnewstoday.com/structure/images/logo/logo-mini-2017.png" alt="MNT home">
				</a>
			</div> 				
			<div id="footer_social">
				<span class="footer_facebook fa-stack fa-lg">
				<a href="https://www.facebook.com/MedicalNewsToday" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-facebook fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_twitter fa-stack fa-lg">
				<a href="https://twitter.com/mnt" target="_blank" rel="noopener noreferrer">
				<i class="fa fa-twitter fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_linkedin fa-stack fa-lg">
				<a href="https://www.linkedin.com/company/mednewstoday" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-linkedin fa-stack-1x fa-inverse"></i>
				</a></span>
				<span class="footer_pinterest fa-stack fa-lg">
				<a href="https://www.pinterest.com/search/pins/?q=www.medicalnewstoday.com" rel="noopener noreferrer" target="_blank">
				<i class="fa fa-pinterest fa-stack-1x fa-inverse"></i>
				</a></span>
			</div> 		
			<div id="footer_list">
				<ul>
								<li><a href="/popular" title="View our most popular news articles">Popular news</a></li>
				<li><a href="/archive" title="View all our editorial articles">Editorial articles</a></li>
				<li><a href="/categories" accesskey="m" title="View our complete news category list">All news topics</a></li>
				<li><a href="/knowledge-center" title="Medical conditions and information center">Knowledge center</a></li>

								<li><a href="/newsletter" title="Medical News Today in your inbox">Newsletters</a></li>


					
				<li><a href="/share-our-content" title="Share our content">Share our content</a></li>

								<li><a href="/about" title="About Medical News Today">About us</a></li>
				<li><a href="/authors" title="Our editorial team">Our editorial team</a></li>
				<li><a href="/contact" title="Contact the Medical News Today team">Contact us</a></li>
				<li><a href="/advertising" title="Advertise with Medical News Today">Advertise with MNT</a></li>
				</ul>
			</div> 				
			<span class="footer_separator">
				<span></span>
			</span> 			
			<div id="footer_newsletter">
					<h3 id="footer_newsletter_h3">get our newsletter</h3>
					<span id="footer_newsletter_span">Health tips, wellness advice and more.</span>
					
					<div class="form-group">
						<form method="post" action="#" name="footerNewsletterSignup" id="footerNewsletterSignup" class="newsletterForm">
						<div>
							<input type="text" name="formEmail" id="EmailAddress" class="newsletterFormEmail" placeholder="Enter your email address" size="25" maxlength="150"/>

							<button type="button"
									data-signup-source="footer_newsletter_link"
									class="btn btn-success btn-lg btn-block btn-footer footer_newsletter_link email-signup-btn new_reg_signup">Subscribe</button>

							<div id="footerNewsletterErrorHolder" class="errorHolder"></div>
							

<p>Your <a href="/privacy-policy" title="Privacy policy">privacy</a> is important to us.</p>

						</div>


						</form>

					</div> 				
			</div> 			
			<span class="footer_separator">
				<span></span>
			</span> 			
			<div id="copyright">
				<div class="honcode_img">
				<a href="https://www.healthonnet.org/HONcode/Conduct.html?HONConduct391155" class="seal" onclick="window.open(this.href); return false;">
				<img src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="https://www.honcode.ch/HONcode/Seal/HONConduct391155_s1.gif" alt="This website is certified by Health On the Net Foundation. Click to verify."></a>
				</div> 				<div class="copyright_text float_left">
					<p>Healthline Media UK Ltd, Brighton, UK.</p>
					<p>&copy; 2004-2019 All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.</p>
				</div> 				<div class="copyright_text float_right">
					<p><a href="/privacy-policy" title="View our privacy policy" onclick="fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'New Header - Desktop - Footer', eventAction: 'Footer - Privacy policy', eventLabel: 'Footer - Privacy policy' });});" >Privacy</a> |
					<a href="/terms" title="View our terms of use" onclick="fireOrSaveJsFunctions(0,function() {ga('send', 'event', { eventCategory: 'New Header - Desktop - Footer', eventAction: 'Footer - Terms', eventLabel: 'Footer - Terms' });});">Terms</a> |
					<a href="/ad-policy" title="View our advertising policy">Ad policy</a> | 
					<a href="https://www.healthline.com/health/careers" title="Careers" rel="noopener" target="_blank">Careers</a></p>
				</div> 			</div> 			
			<div class="footer_truste_container">
				<div class="footer_truste"><a href="//privacy.truste.com/privacy-seal/validation?rid=b59e7a69-59cd-449f-9af4-2bdba7d346e5" rel="noopener noreferrer" target="_blank"><img style="border: none" src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==" data-src="//privacy-policy.truste.com/privacy-seal/seal?rid=b59e7a69-59cd-449f-9af4-2bdba7d346e5" alt="TRUSTe"></a></div>
			</div> 			
		</div> 	
				
	</div> 
</div> 
<footer>

<div id="print_message">
	<p>This page was printed from: <strong><a href="https://www.medicalnewstoday.com/articles/326055.php">https://www.medicalnewstoday.com/articles/326055.php</a></strong></p>
	<p>Visit <strong><a href="https://www.medicalnewstoday.com">www.medicalnewstoday.com</a></strong> for medical news and health news headlines posted throughout the day, every day.</p>
	<hr/>
	<p>2019 Healthline Media UK Ltd. All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.</p>
</div> 



<script type="text/javascript">
		eval(function(p,a,c,k,e,d){e=function(c){return(c<a?'':e(parseInt(c/a)))+((c=c%a)>35?String.fromCharCode(c+29):c.toString(36))};if(!''.replace(/^/,String)){while(c--){d[e(c)]=k[c]||e(c)}k=[function(e){return d[e]}];e=function(){return'\\w+'};c=1};while(c--){if(k[c]){p=p.replace(new RegExp('\\b'+e(c)+'\\b','g'),k[c])}}return p}('3 j=d.1i(\'.A-1p 8\');4(j&&j.c("b-7")){j.7=j.c("b-7");j.1r(\'b-7\')}3 9=[].v.w(d.o(\'8[b-7]\'));3 Q=5(q,g){4(q.g==""){q.g=g}B{3 1d=q.g.1s(" ");4(1d.u(g)==-1){q.g+=" "+g}}};1j(3 i=0;i<9.L;i++){4(9[i].1e.1e.p[0]==\'1n\'){Q(9[i],"A-f")}B{Q(9[i],"f")}}d.m("1t",5(){9=[].v.w(d.o(\'8.A-f\'));9.t(5(2){2.7=2.c("b-7");2.p.D("A-f")});9=[].v.w(d.o(\'8.f\'));3 16=18 6!=="1D";3 13=16&&!("1x"n 6)||/(1w|1y|1z)1E|1A|1H/i.1G(1I.1l);4(13){9.t(5(2){2.7=2.c("b-7");2.p.D("f")})}B{4("V"n 6){4(\'F\'n 6&&\'X\'n 6.F.J&&!(\'O\'n F.J)){1C.1q(6.F.J,\'O\',{1B:5(){1h l.X>0}})}3 G=1F V(5(Y,1v){Y.t(5(S){4(S.O){3 2=S.N;2.p.D("f");2.7=2.c("b-7");M(2);G.1m(2)}})},{1k:"T T 1u T"});9.t(5(2){G.1o(2)})}B{3 y;5 h(){9=[].v.w(d.o(\'.f\'));4(y){1Q(y)}y=2g(5(){3 2k=6.2d;9.t(5(8){4((8.W().27-2c<=6.2l&&8.W().2b>=0)&&2a(8).29!=="26"){8.7=8.c("b-7");8.p.D(\'f\');M(8)}});4(9.L==0){d.U("12",h);6.U("11",h);6.U("10",h)}},20)}h();d.m("12",h);6.m("11",h);6.m("10",h)}5 M(2){2.1J=5(){4(2.c(\'b-I-2-x\')){28(2.c(\'b-I-2-x\'),"",R)}4(2.c(\'b-Z-2-x\')){2e(2.c(\'b-Z-2-x\'),"",1a)}}}}3 K=d.o(\'.2j a:2i(.2h)\');1j(3 E=0;E<K.L;E++){3 C=K[E];4(C.s.u(6.1b.s)===-1&&C.s!=""){C.m("I",5(e){4(e.N.g.u("2-2f")>-1){1h 1f}e.24();3 k=l.s;3 P="17 1g - 25 14 15";3 1c=k;3 H=l.1R;3 z=l.1i("8");4(z){H=z.1S||z.1P}3 r=1f;4(18 k!=="1O"&&k.u("1K.1L")===-1){r=R;P="17 1g - 1M 14 15"}4(l.N==="1N"){r=R}4(r){3 19=6.1T(k);19.1U=1a}21(0,5(){22(\'23\',\'1Z\',{1Y:P,1V:H,1W:1c,1X:5(){4(!r){6.1b.s=k}}})})})}}});',62,146,'||image|var|if|function|window|src|img|lazyloadImages||data|getAttribute|document||lazy|className|lazyload||owlCarouselFirstImage|originHref|this|addEventListener|in|querySelectorAll|classList|element|newWindow|href|forEach|indexOf|slice|call|index|lazyloadThrottleTimeout|imageDom|owl|else|linkDOM|remove|articleIndex|IntersectionObserverEntry|imageObserver|gaAction|click|prototype|linksInArticle|length|includeImagePlugin|target|isIntersecting|gaCategory|addLazyClass|true|entry|0px|removeEventListener|IntersectionObserver|getBoundingClientRect|intersectionRatio|entries|sharing|orientationChange|resize|scroll|isBot|Link|Click|runningOnBrowser|Article|typeof|newWnd|null|location|gaLabel|arr|parentNode|false|Body|return|querySelector|for|rootMargin|userAgent|unobserve|item|observe|carousel|defineProperty|removeAttribute|split|DOMContentLoaded|300px|observer|gle|onscroll|ing|ro|crawl|get|Object|undefined|bot|new|test|spider|navigator|onload|medicalnewstoday|com|Outbound|_blank|undefiend|alt|clearTimeout|innerHTML|title|open|opener|eventAction|eventLabel|hitCallback|eventCategory|event||fireOrSaveJsFunctions|ga|send|preventDefault|Internal|none|top|loadClickableImageByIndex|display|getComputedStyle|bottom|300|pageYOffset|loadImageSharingImageByIndex|clickable|setTimeout|collapsed__click|not|article_body|scrollTop|innerHeight'.split('|'),0,{}))

</script>
<script type="text/javascript">
	window.ga=window.ga||function(){};
	if (typeof window.googletag === 'undefined') {
		//Fallback safe for googletag
    	var googletag = googletag || { };
		googletag.cmd = googletag.cmd || [ ];
	}
	
	//Fallback for Adbridg
	if (typeof window.AdBridg === 'undefined') {
		var AdBridg = AdBridg || {};
  		AdBridg.cmd = AdBridg.cmd || [];
	}

</script>







<script type="text/javascript">



		vanillaAjax("https://pavlov-prod.healthline.com/api/metrics","POST",'{"metrics":[{"type":"increment","name":"ui.pageview"}],"build":"1","route":"php","path":"/articles/326055.php","formfactor":"desktop","site":"mnt","abSegment":""}','{"Content-Type":"text\/plain;charset=UTF-8"}');






</script>


<script type="text/javascript" >
			var is_userMobile=0;
			var is_userTablet=0;
			var glob_responsiveOverride=0;
			var glob_customUserID=0;
			var category=[{"displayNavName":"ADHD \/ ADD","url":"adhd"},{"displayNavName":"Allergy","url":"allergy"},{"displayNavName":"Alzheimer's \/ Dementia","url":"alzheimers"},{"displayNavName":"Anxiety \/ Stress","url":"anxiety"},{"displayNavName":"Rheumatology","url":"rheumatology"},{"displayNavName":"Respiratory","url":"respiratory"},{"displayNavName":"Bipolar","url":"bipolar"},{"displayNavName":"Body Aches","url":"bodyaches"},{"displayNavName":"Breast Cancer","url":"breast_cancer"},{"displayNavName":"Cancer \/ Oncology","url":"cancer-oncology"},{"displayNavName":"Cardiovascular \/ Cardiology","url":"cardiovascular"},{"displayNavName":"Caregivers \/ Homecare","url":"caregivers"},{"displayNavName":"Cholesterol","url":"cholesterol"},{"displayNavName":"Crohn's","url":"crohns"},{"displayNavName":"Cystic Fibrosis","url":"cystic_fibrosis"},{"displayNavName":"Depression","url":"depression"},{"displayNavName":"Dermatology","url":"dermatology"},{"displayNavName":"Diabetes","url":"diabetes"},{"displayNavName":"Erectile Dysfunction","url":"erectile_dysfunction"},{"displayNavName":"Fertility","url":"fertility"},{"displayNavName":"Obesity \/ Weight Loss \/ Fitness","url":"fitness-obesity"},{"displayNavName":"Headache \/ Migraine","url":"headache-migraine"},{"displayNavName":"Liver Disease \/ Hepatitis","url":"liver_disease"},{"displayNavName":"HIV and AIDS","url":"hiv-aids"},{"displayNavName":"Hypertension","url":"hypertension"},{"displayNavName":"Irritable Bowel Syndrome","url":"ibs"},{"displayNavName":"Lung Cancer","url":"lung_cancer"},{"displayNavName":"Lymphoma","url":"lymphoma"},{"displayNavName":"Men's Health","url":"mens_health"},{"displayNavName":"Mental Health","url":"mental_health"},{"displayNavName":"Neurology \/ Neuroscience","url":"neurology"},{"displayNavName":"Pregnancy \/ Obstetrics","url":"pregnancy"},{"displayNavName":"Psychology \/ Psychiatry","url":"psychology-psychiatry"},{"displayNavName":"Schizophrenia","url":"schizophrenia"},{"displayNavName":"Seniors \/ Aging","url":"seniors"},{"displayNavName":"Sexual Health \/ STDs","url":"sexual_health"},{"displayNavName":"Statins","url":"statins"},{"displayNavName":"Urology \/ Nephrology","url":"urology-nephrology"},{"displayNavName":"Women's Health","url":"womens_health"},{"displayNavName":"Pediatrics \/ Children's Health","url":"pediatrics"},{"displayNavName":"Radiology \/ Nuclear Medicine","url":"radiology"},{"displayNavName":"Bones \/ Orthopedics","url":"bones"},{"displayNavName":"Public Health","url":"public_health"},{"displayNavName":"Bio-terrorism \/ Terrorism","url":"bioterrorism"},{"displayNavName":"Aid \/ Disasters","url":"aid-disasters"},{"displayNavName":"Genetics","url":"genetics"},{"displayNavName":"Ear, Nose and Throat","url":"ent"},{"displayNavName":"Alcohol \/ Illegal Drugs","url":"alcohol"},{"displayNavName":"Nursing \/ Midwifery","url":"nursing"},{"displayNavName":"Medical Students \/ Training","url":"medical_students"},{"displayNavName":"Pharma \/ Biotech Industry","url":"pharma_industry"},{"displayNavName":"Stem Cell Research","url":"stem_cell"},{"displayNavName":"Dentistry","url":"dentistry"},{"displayNavName":"Bird Flu \/ Avian Flu","url":"birdflu"},{"displayNavName":"MRSA \/ Drug Resistance","url":"mrsa-superbug"},{"displayNavName":"Eye Health \/ Blindness","url":"eye_health"},{"displayNavName":"Tropical Diseases","url":"tropical_diseases"},{"displayNavName":"Cleft Palate","url":"cleft_palate"},{"displayNavName":"Infectious Diseases","url":"infectious_diseases"},{"displayNavName":"Parkinson's Disease","url":"parkinsons_disease"},{"displayNavName":"GastroIntestinal","url":"gastrointestinal"},{"displayNavName":"CJD \/ vCJD \/ Mad Cow Disease","url":"cjd-vcjd"},{"displayNavName":"Nutrition \/ Diet","url":"nutrition-diet"},{"displayNavName":"Gout","url":"gout"},{"displayNavName":"Stroke","url":"stroke"},{"displayNavName":"Complementary Medicine","url":"complementary_medicine"},{"displayNavName":"Endocrinology","url":"endocrinology"},{"displayNavName":"Biology \/ Biochemistry","url":"biology-biochemistry"},{"displayNavName":"Multiple Sclerosis","url":"multiple_sclerosis"},{"displayNavName":"Autism","url":"autism"},{"displayNavName":"Water - Air Quality \/ Agriculture","url":"water_quality"},{"displayNavName":"Immune System \/ Vaccines","url":"immune_system"},{"displayNavName":"Lupus","url":"lupus"},{"displayNavName":"Cosmetic Medicine","url":"cosmetic_medicine"},{"displayNavName":"Rehabilitation","url":"rehabilitation"},{"displayNavName":"Pain \/ Anesthetics","url":"pain"},{"displayNavName":"Hearing \/ Deafness","url":"hearing-deafness"},{"displayNavName":"Muscular Dystrophy \/ ALS","url":"muscular_dystrophy"},{"displayNavName":"Sports Medicine \/ Fitness","url":"sports_medicine"},{"displayNavName":"MRI \/ PET \/ Ultrasound","url":"mri-pet"},{"displayNavName":"Huntingtons Disease","url":"huntingtons_disease"},{"displayNavName":"Medical Devices \/ Diagnostics","url":"medical_devices"},{"displayNavName":"Smoking \/ Quit Smoking","url":"smoking"},{"displayNavName":"Transplants \/ Organ Donations","url":"transplants"},{"displayNavName":"Sleep \/ Sleep Disorders","url":"sleep"},{"displayNavName":"IT \/ Internet \/ E-mail","url":"it"},{"displayNavName":"Dyslexia","url":"dyslexia"},{"displayNavName":"Medicare \/ Medicaid \/ SCHIP","url":"medicare-medicaid"},{"displayNavName":"Epilepsy","url":"epilepsy"},{"displayNavName":"Prostate \/ Prostate Cancer","url":"prostate"},{"displayNavName":"Veterinary","url":"veterinary"},{"displayNavName":"Abortion","url":"abortion"},{"displayNavName":"Health Insurance","url":"health_insurance"},{"displayNavName":"Litigation","url":"medical_malpractice"},{"displayNavName":"Clinical Trials \/ Drug Trials","url":"clinical_trials"},{"displayNavName":"Conferences","url":"conferences"},{"displayNavName":"Compliance","url":"compliance"},{"displayNavName":"Primary Care \/ General Practice","url":"primary_care"},{"displayNavName":"Flu \/ Cold \/ SARS","url":"flu-sars"},{"displayNavName":"Blood \/ Hematology","url":"blood"},{"displayNavName":"Colorectal Cancer","url":"colorectal_cancer"},{"displayNavName":"Acid Reflux \/ GERD","url":"gerd"},{"displayNavName":"Cervical Cancer \/ HPV Vaccine","url":"cervical_cancer"},{"displayNavName":"Eating Disorders","url":"eatingdisorders"},{"displayNavName":"Pharmacy \/ Pharmacist","url":"pharmacy"},{"displayNavName":"Regulatory Affairs","url":"regulatoryaffairs"},{"displayNavName":"Ovarian Cancer","url":"ovarian_cancer"},{"displayNavName":"Menopause","url":"menopause"},{"displayNavName":"Psoriasis","url":"psoriasis"},{"displayNavName":"Tuberculosis","url":"tuberculosis"},{"displayNavName":"Back Pain","url":"back-pain"},{"displayNavName":"Heart Disease","url":"heart-disease"},{"displayNavName":"Asbestos \/ Mesothelioma","url":"asbestos"},{"displayNavName":"Lymphology \/ Lymphedema","url":"lymphology"},{"displayNavName":"Veterans \/ Ex-Servicemen","url":"veterans"},{"displayNavName":"Medical Practice Management","url":"medical_practice"},{"displayNavName":"Melanoma \/ Skin Cancer","url":"melanoma"},{"displayNavName":"COPD","url":"copd"},{"displayNavName":"Palliative Care \/ Hospice Care","url":"palliative_care"},{"displayNavName":"Vascular","url":"vascular"},{"displayNavName":"Fibromyalgia","url":"fibromyalgia"},{"displayNavName":"Pancreatic Cancer","url":"pancreatic-cancer"},{"displayNavName":"Preventive Medicine","url":"preventive-medicine"},{"displayNavName":"Swine Flu","url":"swine-flu"},{"displayNavName":"Restless Legs Syndrome","url":"restless-legs"},{"displayNavName":"Food Intolerance","url":"food-intolerance"},{"displayNavName":"Personal Monitoring","url":"personal-monitoring"},{"displayNavName":"Surgery","url":"surgery"},{"displayNavName":"Emergency Medicine","url":"emergency-medicine"},{"displayNavName":"Pulmonary System","url":"pulmonary-system"},{"displayNavName":"Medical Innovation","url":"medical-innovation"},{"displayNavName":"Ebola","url":"ebola"},{"displayNavName":"Ulcerative Colitis","url":"ulcerative-colitis"},{"displayNavName":"Constipation","url":"constipation"},{"displayNavName":"Arrhythmia","url":"arrhythmia"},{"displayNavName":"Osteoporosis","url":"osteoporosis"},{"displayNavName":"Diabetes Type 1","url":"diabetes-type-1"},{"displayNavName":"Diabetes Type 2","url":"diabetes-type-2"},{"displayNavName":"Dry Eye","url":"dry-eye"},{"displayNavName":"Endometriosis","url":"endometriosis"},{"displayNavName":"Psoriatic Arthritis","url":"psoriatic-arthritis"},{"displayNavName":"Hypothyroid","url":"hypothyroid"},{"displayNavName":"Shingles","url":"shingles"},{"displayNavName":"Premature Ejaculation","url":"premature-ejaculation"},{"displayNavName":"Asthma","url":"asthma"},{"displayNavName":"VTE","url":"vte"},{"displayNavName":"Seasonal Allergy","url":"seasonal-allergy"},{"displayNavName":"Food Allergy","url":"food-allergy"},{"displayNavName":"OAB","url":"oab"},{"displayNavName":"Urinary Tract Infection","url":"urinary-tract-infection"},{"displayNavName":"Leukemia","url":"leukemia"},{"displayNavName":"Osteoarthritis","url":"osteoarthritis"},{"displayNavName":"Rheumatoid Arthritis","url":"rheumatoid-arthritis"},{"displayNavName":"Birth Control","url":"birth-control-contraception"},{"displayNavName":"Head and Neck Cancer","url":"head-and-neck-cancer"},{"displayNavName":"Atopic Dermatitis","url":"atopic-dermatitis-eczema"},{"displayNavName":"Bites and Stings","url":"bites-stings"}];
			var glob_testServer = 0;
			var resetpw = 0;
			var glob_newSkin = 1;
			var glob_menu_prefix = 'New Header';
			var glob_deviceInfo = 'Desktop';
			var glob_newRegistration = 1;
			var glob_triggerSurvey = 0;
			var glob_pageType = 'article';
			var glob_siteRevision = 7721;
			var showNewsletterPopup = 1;
			var showFocusGroupPopup = 0;
			</script>



							<script type="text/javascript" src="https://cdn-prod.medicalnewstoday.com/structure/javascript/out/mnt_default.js?v=190904" defer></script>
				
		<script src="https://healthline-com.videoplayerhub.com/galleryloader.js" defer></script>

	




<script type="text/javascript">

	fireOrSaveJsFunctions(1,function(){

		var tempAacctTid =setInterval(function() {

			if(typeof _qevents !== "undefined"){
				//wait until _qevents had been set
				_qevents.push( { qacct:"p-v03RmX3GES6RT"} );
				clearInterval(tempAacctTid);
			}

		}, 500);

	});

</script>
<noscript>
	<div style="display: none;">
		<img src="https://pixel.quantserve.com/pixel/p-test123.gif" height="1" width="1" alt="Quantcast"/>
	</div>
</noscript>


<script src="https://cdn-prod.medicalnewstoday.com/structure/javascript/cache/oct.js" type="text/javascript"></script>
<script type="text/javascript">

	fireOrSaveJsFunctions(1,function(){
		twttr.conversion.trackPid('l4bfr');
	});

</script>
<noscript>
	<img height="1" width="1" style="display:none;" alt="" src="https://analytics.twitter.com/i/adsct?txn_id=l4bfr&p_id=Twitter" />
</noscript>



<div id="fb-root"></div>
<script>


	fireOrSaveJsFunctions(1,function(){

		(function(d, s, id) {
  var js, fjs = d.getElementsByTagName(s)[0];
  if (d.getElementById(id)) return;
  js = d.createElement(s); js.id = id;
  js.src = "//connect.facebook.net/en_US/sdk.js#xfbml=1&version=v2.3&appId=147184211975697";
  fjs.parentNode.insertBefore(js, fjs);
		}(document, 'script', 'facebook-jssdk'));

	});


</script>






<script>
	glob_categoryID="40";glob_categoryName="Urology / Nephrology category";glob_bindingK1="otherurinarydisorders";</script>



<div id="amzn-assoc-ad-c3555b57-ee3e-4ba5-b6f4-ec40911af7e4"></div>
<script>

	fireOrSaveJsFunctions(1,function(){loadScript(
		"//z-na.amazon-adsystem.com/widgets/onejs?MarketPlace=US&adInstanceId=c3555b57-ee3e-4ba5-b6f4-ec40911af7e4",
		{},
		function(){}

	)});

</script>


	<script>
		// 1. create object of script
		var deferCSS = document.createElement('script');
		deferCSS.src = 'https://hello.myfonts.net/count/333229';
		deferCSS.type = 'text/javascript';
		deferCSS.defer = true;

		// 2. declaire position of </body>
		var deferCSS_place = document.getElementsByTagName('body')[0];

		// 3. insert object before </body>
		deferCSS_place.appendChild(deferCSS);
	</script>




<!-- Begin medicalnewstoday.com BlueKai Tag --> 
<script type="text/javascript"> 
window.bk_async = function() { 
	bk_addPageCtx('categoryMain', 'urology-nephrology');
	bk_addPageCtx('categorySub', '');
	bk_addPageCtx('dimension28', 'kidneycancer');
	bk_addPageCtx('dimension29', 'cancer');
	BKTAG.doTag(76945, 10);
}; 
(function() { 
	var scripts = document.getElementsByTagName('script')[0]; 
	var s = document.createElement('script'); 
	s.async = true; 
	s.src = "https://tags.bkrtx.com/js/bk-coretag.js"; 
	scripts.parentNode.insertBefore(s, scripts); 
}()); 
</script> 
<!-- End BlueKai Tag --> 




<script type="text/javascript" >
				var articleID="326055";
				var articleType = "drugs";
				var emailID = "326055";
				var articleURL = "/articles/326055.php";
				var threadID = "0";
				var opinionsOutput = 0;
				var showAdsOnArticle = 1;
				var isSponsored = 0;
				</script>
    <script type="text/javascript">
    
		for(var contentBlocksDoms=document.querySelectorAll(".infobox_large.article-tcblocks > li"),i=0;i<contentBlocksDoms.length;i++){var _this=contentBlocksDoms[i],mobileHeadline=_this.querySelector("a  > div.headline.mobile"),excerpt=_this.querySelector("a > div > .excerpt"),desktopHeadlineHtmlStr=mobileHeadline.outerHTML;desktopHeadlineHtmlStr=desktopHeadlineHtmlStr.replace(/(class=\".*?)\s*mobile\s*(.*?\")/g,"$1$2"),null===_this.querySelector("a > div > .headline")&&excerpt.insertAdjacentHTML("beforebegin",desktopHeadlineHtmlStr),_this.getElementsByTagName("a")[0].removeChild(mobileHeadline)}

		//Remove  class hide in tabbed content to show on desktop/ tablet
		if(document.getElementsByClassName("collapsed__tabs")[0]){
			document.getElementsByClassName("collapsed__tabs")[0].classList.remove('hide');	
		}

    </script>



	<script type="text/javascript">

		var articleTOC = document.getElementsByClassName("article_toc")[0];

		if(document.body.contains(articleTOC)){
			// if the page contains article TOC, we do the trick
			var articleTOCpreviousElement = articleTOC.previousElementSibling;

			if(articleTOCpreviousElement){
				if((articleTOCpreviousElement.className.indexOf("photobox_header") !==-1&&articleTOCpreviousElement.querySelector("em") != null)||(articleTOCpreviousElement.className.indexOf("photobox_left") !==-1&&articleTOCpreviousElement.querySelector("em") != null)||(articleTOCpreviousElement.className.indexOf("photobox_right") !==-1&&articleTOCpreviousElement.querySelector("em") != null)){
					articleTOC.classList.add("article_collapsed--top");
				}
			}

		}

	</script>



	<input type="hidden" id="newsid" name="newsid" value="326055">
	<input type="hidden" id="categoryid" name="categoryid" value="40">
	<input type="hidden" id="glob" name="glob" value="0">
	<input type="hidden" id="ratingHCP" name="ratingHCP" value="0">
	<input type="hidden" id="ratingPublic" name="ratingPublic" value="0">
	<input type="hidden" id="alreadyRated" name="alreadyRated" value="0">
	<input type="hidden" id="kcarticle" name="kcarticle" value="0">
	<input type="hidden" id="bottomRatingsBoxReadOnly" name="bottomRatingsBoxReadOnly" value="true">
		
	
				<script type="text/javascript" src="https://cdn-prod.medicalnewstoday.com/structure/javascript/out/mnt_article_7721.js" defer></script>
		

		




<script type="text/javascript">
var mntDataLayer = "";
//Fire in adblock.js cause that's the last event in the page 
function setMNTDataLayer(e) {
	mntDataLayer = {"article_meta":{"publisher":"Medical News Today","headline":"Afinitor (everolimus)","description":"Afinitor (everolimus) is a brand-name prescription medication. It\u2019s used to treat certain types of cancers, tumors, and seizures. It comes as an oral tablet (Afinitor) and as a tablet for oral suspension (Afinitor Disperz). Learn about side effects, cost, uses and more.","url":"\/articles\/326055.php","CanonicalURL":"https:\/\/www.medicalnewstoday.com\/articles\/326055.php","datePublished":"2019-08-31","dateUpdated":"","dateReviewed":"2019-05-23","author":"Victor Nguyen, PharmD, MS","coAuthor":"","reviewer":"Catherine C. Peng, PharmD, BCPS","ratingHCP":0,"ratingPublic":0,"commentCount":0,"shareCountFacebook":0,"shareCountGooglePlus":0,"shareCountLinkedIn":0,"shareCountPinterest":0,"ampURL":"","ampVersion":"N"},"reader":{"loggedIn":"no"},"targeting":{"categoryMain":"urology-nephrology","categorySub":[""],"articleKeywords":"","articleID":"326055","articleType":"drugs","micrositeID":"afinitorcdi","articleVersion":"v2","articleAge":"week"},"customDimensions":{"siteVersion":"desktop","webServer":-1,"iosAppTraffic":-1,"viewportWidth":0,"viewportHeight":0,"hidpi":0,"adblockStatus":0}}
	mntDataLayer["article_meta"]["shareCountFacebook"] 	 = facebookCount;
	mntDataLayer["article_meta"]["shareCountGooglePlus"] = googlePlusCount;
	mntDataLayer["article_meta"]["shareCountLinkedIn"] 	 = linkedinCount;
	mntDataLayer["article_meta"]["shareCountPinterest"]	 = pinterestCount;
	mntDataLayer["article_meta"]["url"]	 				 = window.location.href;
	mntDataLayer["customDimensions"]["adblockStatus"] 	 = adBlockValue;
 	mntDataLayer["customDimensions"]["viewportWidth"] = Math.max(document.documentElement.clientWidth, window.innerWidth || 0);
 	mntDataLayer["customDimensions"]["viewportHeight"] = Math.max(document.documentElement.clientHeight, window.innerHeight || 0);
 	mntDataLayer["customDimensions"]["hidpi"] = (window.devicePixelRatio >= 1.5) ? "HiDPI" : "1X";
}
</script>

					
			
</div> </body>
</html>
